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1.INTRODUCTION 
MEDICINAL PLANTS 
Various plants have been used for medicinal purpose long before prehistoric 
period. Traditional systems of medicine continue to be widely practiced on many 
accounts. population rise inadequate supply of drugs prohibitive cost of treatments, 
side effects of several synthetic drugs and development of resistance to currently used 
drugs for infection disease have led to increased emphasis on the use of plant 
materials as a source of medicines for a wide variety of human ailments. Among 
ancient civilization india has been known to be rich repository of medicinal plants. 
About 8000 herbal remedies have been codified in AYUSH systems in india. 
ayurveda, unani, siddha and folk (tribal) medicines are the major systems of 
indigenous medicines. Among these systems, ayurveda and unani medicines are most 
developed and widely practised in india.according to WHO around 21000 plant 
species have the potential for being used as medicinal plants.The economic 
importance of medicinal plants is much more to countries provide two third of plants 
used in modern systems of medicine and health care system of rural population 
depend on indigenous systems of medicine. Treatment with medicinal plants is 
considered very safety as there is no or minimal side effects. there remedies are in 
sync with nature.which is biggest advantage. The golden fact is that use of herbal 
treatments is independent of any age groups and sexes.The most of the drugs thus 
formulated are of side effects or reactions.this is the reason why medicinal  treatment 
growing in popularity across the globe. Medicinal plants are considered as a rich 
resources of ingredients which can be used in drug development either 
pharmacopoeial or synthetic drugs. 
WHY PEOPLE WITH CANCER USE NATURAL MEDICINES. 
People with cancer offen use touch therapies such as massage and aroma 
therapy,etc. Many people say these therapies help them to cope better with cancer and 
its treatment.Research is looking into whether some herbs or plant treatments used in 
ayurvedic   medicine could help to prevent or treat cancer.But we still don't know 
much about some of the treatments that are part of ayurvedic medicine such as special 
diets and herbal remedies. 
 Department of Pharmacology                     2                    J.K.K.Nataraja College of Pharmacy 
 
Although great advancements have been made in the treatment and control of 
cancer. progression significant deficiencies and room for improvement remain. plants 
have enormous potential to provide newer drugs and as such are a reservoir of natural 
chemicals that may provide chemo productive potential against cancer. A number of 
side effects sometimes occur during chemotherapy. Natural therapies such as the use 
of plant derived products in cancer treatment may reduce adverse side effects. 
Currently a few plant products are being used to treat cancer. However a myriad of 
many plant products exist that have shown very promising anti cancer properties in 
vitro but rare yet to be evaluated in humans.  
Further study is required to determine the efficacy of these plants products in 
treating cancer in humans  
TUMOR1: 
            Neoplasia literally means the process of "new growth," and a new growth is called 
a neoplasm. The term tumor was originally applied to the swelling caused by 
inflammation. Neoplasms also may induce swellings, but by long precedent, the non-
neoplastic usage of tumor has passed into limbo; thus, the term is now equated with 
neoplasm. Oncology (Greek oncos = tumor) is the study of tumors or neoplasms. Cancer 
is the common term for all malignant tumors. Although the ancient origins of this term 
are somewhat uncertain, it probably derives from the Latin for crab, cancer-presumably 
because a cancer "adheres to any part that it seizes upon in an obstinate manner like the 
crab."  
 
1. DEFINITIONS: 
Solid tumors are defined as abnormal masses of tissue that usually do not 
contain cysts or liquid areas. Solid tumors may be benign (not cancerous), or 
malignant (cancerous). A number of malignant diseases are often also categorized as 
“solid tumors” such as breast cancer, cancer of the pancreas, lung, colon, etc. 
 
 Solid tumors can be split into three separate categories, depending on the type of 
cells from which they typically arise in the patient’s body, which include: 
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 Sarcomas: Cancers arising from connective or supporting tissues such as bone 
or muscle. 
 Carcinomas: Cancers arising from the body's glandular cells and epithelial 
cells, which line the air passages and gastrointestinal tract. 
 Lymphomas: Cancers of the lymphoid organs such as lymph nodes, spleen, 
and thymus, which produce and store infection-fighting cells. Lymphoma is 
cancer of the lymphatic system, which is part of the immune system.  
Lymphoma is a form of cancer that affects the immune system - specifically, it is 
a cancer of immune cells called lymphocytes, a type of white blood cell. There are 
two broad types of lymphoma and many subtypes. 
                                
Figure.1 The lymphatic system is a system of vessels that branch back from virtually 
all our tissues to drain excess fluids and present foreign material to the lymph nodes.  
The two types of lymphoma are described as: Hodgkin's or non Hodgkin's. 
Lymphoma can occur at any age but is the most common cancer in young people. It is 
often very treatable, and most people live for a long time after being diagnosed. 
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About 90% of lymphomas are the non-Hodgkin's type while about 10% 
are Hodgkin's. 
 
Cancer is a group of over 100 diseases, all of which start with the growth of 
abnormal cells. Instead of dying in the normal cell life cycle, cancerous cells continue 
to divide into new abnormal cells, and grow out of control. 
 
  
 
 
 
 
 
 
 
 
                                                 figure.2  lymphatic cancer 
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Lymphatic cancers are classified by the type of immune cells affected. 
In non-Hodgkin's lymphoma, B-cells and T-cells are affected - both being 
types of lymphocyte white blood cell with special roles in immunity. In the US, B-cell 
lymphomas are much more common than T-cell ones. 
In Hodgkin's lymphoma, the cancer cells are usually an abnormal type of B 
lymphocyte, named Reed-Sternberg cells. There are many subtypes of Hodgkin's 
lymphoma, typed by differences seen under the microscope - but a very high 
percentage of cases are classed as "classic" Hodgkin's. 
Types of lymphoma 
There are many different types of lymphoma depending on the type of 
lymphatic cells affected. 
 
Hodgkin's lymphoma can occur at any age, affects more men than women and 
the majority will be completely cured. 
Hodgkin's lymphoma is diagnosed when a special type of cell, the Reed-
Sternberg cell, is seen under the microscope. 
Non-Hodgkin's lymphoma accounts for all the other types of lymphoma. 
These can be high grade or low grade and the treatment and prognosis varies. 
Factors for Non-Hodgkin's lymphoma 
 Age - most non-Hodgkin lymphomas are in people 60 years of age and over 
 Sex - there are different rates of different types of non-Hodgkin's lymphoma across 
the sexes 
 Ethnicity and location - in the US, African-Americans and Asian-Americans are 
less prone than white Americans, and the disease is more common in developed 
nations of the world 
 Chemicals and radiation - some chemicals used in agriculture have been linked, 
as has nuclear radiation exposure 
 Immune deficiency - for example, caused by HIV infection or in organ 
transplantation 
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 Autoimmune disease, in which the immune system attacks the body's own cells 
 Infection - certain viral and bacterial infections increase the risk. The Helicobacter 
Infection has been implicated, as has the Epstein Barr Virus (the virus that 
causes glandular fever) 
 See the American Cancer Society's page for more detail on risk factors for non-
Hodgkin's lymphoma. 
Factors for Hodgkin's lymphoma 
 Infectious mononucleosis - infection with Epstein-Barr virus 
 Age - two specific groups are most affected: typically people in their 20s, and 
people over the age of 55 years 
 Sex - slightly more common in men 
 Location - most common in the US, Canada and northern Europe; least common in 
Asia 
 Family - if a sibling has the condition, the risk is slightly higher, and very high if 
there is an identical twin 
 Affluence - people from higher socioeconomic status are at greater risk 
 HIV infection 
 See the American Cancer Society's page for more detail on risk factors for 
Hodgkin's lymphoma. 
 
Symptoms of lymphoma 
The symptoms and signs of lymphoma are very similar to those of simple 
illnesses such as viral illnesses and the common cold, and this can cause problems 
with delayed diagnosis. 
The difference is that the symptoms of lymphoma persist long after the usual run of 
a viral infection. 
 Swelling in the legs or ankles 
 Cramping and bloating of the abdomen 
 Night sweats and fever 
 Weight loss and loss of appetite 
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 Chills 
 Unusual itching 
 Fatigue 
 Pain or altered sensation 
 Loss of appetite 
 Unusual tiredness/lack of energy 
 Persistent coughing 
 Breathlessness 
 Enlarged tonsils 
 Headache. 
Treatments and prevention 
A number of treatment options are used against lymphoma cancer these are 
 Radiation therapy 
 Biologic therapy 
 Antibody therapy 
 Stem-cell transplantation 
 Splenectomy 
 Steroid treatment 
 Radioimmunotherapy 
 Surgery. 
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1.2 ANTIOXIDANTS: 
Free radical is a chemical compound which contains an unpaired electron 
spinning on the peripheral layer around the nucleus.  The  family  of  free  radicals  
generated  from the oxygen  is called ROS which cause damage  to other molecules  
by  extracting  electrons  from  them  in  order  to attain  stability.  ROS  are  ions,  
atoms  or  molecules  that have  the  ability  to  oxidize  reduced molecules. ROS  are 
various  forms  of  activated  oxygen,  which  include  free radicals  such  as  
superoxide  anion  radicals (O2.) And hydroxyl radicals (OH), as well as non-free 
radicals (H2O2) and singlet oxygen2.  In the body, free radicals are derived from two 
sources: endogenous sources, e.g. Nutrient metabolism, ageing process etc and 
exogenous sources e.g.  Tobacco smoke, ionizing radiation, air pollution, organic 
solvents, pesticides3. 
When oxygen  traps  single electron,  it becomes unstable  and  thus  very  
reactive,  since  it  generates  harmful chain  reactions  against many  biological 
molecules.  The extreme  toxicity of oxygen  is related  to  its high capability of  
generating  free  radicals  and  in  turn  destroying many major biological molecules. 
They can attack on lipids and proteins and destroy membranes. ROS can damage 
DNA and lead to mutation and chromosomal damage. Oxidized  cellular  thiols  
abstract  hydrogen  atoms  from  unsaturated  fatty  acids  to  initiate  the  peroxidation  
of membrane  lipids4.  ROS can attack various substrates in body and contribute to 
development of chronic diseases. Exogenous chemicals and endogenous metabolic 
processes  in  human  body  produce  free  radicals,  especially oxygen  derived  
radicals, which  are  capable  of  oxidizing biomolecules,  resulting  in  cell  death.  
Superoxide anion radicals increase under stress conditions such as heavy exercise, 
certain drugs, infection and various disease states. During normal metabolic 
processes, human body generates more than 2 Kg of O2 per year5. 
  Cells are equipped with different kinds of mechanisms to fight against ROS 
and to maintain the redox homeostasis of cell. For example, antioxidant enzymes such 
as superoxide  dismutase  (SOD),  catalase  (CAT)  and glutathione  peroxidase  
(GPx)  play  important  roles  inscavenging  the  free  radicals  and  preventing  cell  
injury6. Molecules such as vitamin C and E inhibit lipid peroxidation in cell. When 
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the mechanism of antioxidant  protection  becomes  unbalanced  in  human body,  
antioxidant  supplement  may  be  used  to  help reduce oxidative damage. 
    
Table.1  Some selected antioxidants and their mechanisms of action12: 
Antioxidants Mechanisms of action 
SOD Dismutation of superoxide to H2O2 
CAT 
Decomposes H2O2 to molecular oxygen 
and water 
GSH Intracellular reducing agent 
Lycopene Trapping of singlet oxygen 
Quercetin 
H2O2 scavenging, one of the potent 
antioxidant among polyphenols 
Vitamin E Direct scavenging of superoxide 
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Figure.3 Classification of antioxidants 
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1.3 FLAVONOIDS: 
 Flavonoids are found in higher vascular plants, particularly in the flower, 
leaves and bark.  They are especially abundant in fruits, grains and nuts, 
particularly in the skins. 
 Beverages consisting of plant extracts (beer, tea, wine, fruit juice) are the 
principle source of dietary flavonoid intake.  A glass of red wine has ~200 
mg of flavonoids. 
 Typical flavonoid intake ranges from 50 to 800 mg/day, which is roughly 5, 
50 and 100 times that of Vitamins C, and E, and carotenoids respectively. 
1.3.1 Flavonoids role in cancer13: 
 Few diseases are feared more than cancer because cancerous diseases, after 
cardiovascular disorders and accidents, kill more people before a normal life span has 
been reached. Besides, the progress of cancer is often accompanied by great pain and 
ugly disfiguration of the body. Yet, in principle, cancer is curable if it is discovered 
early and treated with the best current therapeutic methods. However, radical cancer 
cure is fraught with considerable life-threatening dangers, loss of organs, pain, and 
discomfort. Besides, its treatment is expensive. Hence, it is understandable that many 
cancer patients look for and try milder anticancer therapies that offer some promise of 
a moderate, long-term life-saving cure. The flavonoids are some of the most 
promising anticancer natural products that have been tried. Related synthetic 
substances, e.g., flavone acetic acid, have been subjected to Phase I clinical trials 
already, and they may soon become adopted into the general repertoire of cytostatic 
treatment. 
1.3.2 Flavonoids role in anti oxidants: 
a. Enhance or mimic antioxidant enzymes. 
b. Direct scavenging of ROS. 
c. Repair damaged cellular components. 
d. Pro-oxidant metal deactivation 
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Flavonoid and related compound are effective in scavenging DPPH radical14, 
hydroxyl radical and in metal-chelating capacity. Flavonoids are found to exhibit 
numerous biological activities like vasodilatory, anti carcinogenic, anti-inflammatory, 
antibacterial, immune-stimulating, antiallergic, and antiviral effects 15. 
1.4 CELL LINES16: 
If the specified number of cells of inoculated in to sensitive mouse strain, 
tumors can be developed rapidly as compared to chemical carcinogen-induced tumors 
and time can saved using this model. 
1.4.1 METHODS INVOLVED IN CELL LINES: 
L-1210 and P-388 cell lines are used. These cell lines are derived from mouse 
lymphatic leukemia and have 100% growth fraction and tumor implanted with 
specified number of L-1210 or P-388 cells can be predicted. The effective drug would 
retard the tumor growth and increase the life span of the animal. A drug, which 
prolongs the lifespan of the animal by 20%, is taken for subsequent studies involving 
testing on other transplantable tumors. Some other cell lines which can be inoculated 
to induce tumors are B-16(melanoma), Lewis lung carcinoma and sarcoma-180, etc. 
The host mouse strain for above type of cell lines is BDF, except Swiss for sarcoma-
180. P-388 and L-1210 cell lines are inoculated intraperitonially and sarcoma-180 as 
subcutaneously. The experiment takes about 10 days for completion 
 
ILS (%) = [(Mean survival of treated group/ Mean survival of control group)-1] x100 
For sarcoma-180 tumors, reduction of tumor size (tumor weight) is used to 
find out the inhibiting activity of solid tumors as follows. 
 
Tumor inhibiting activity =(average tumor weight of the treated group/average 
tumor weight of control group) x 100 
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Hollow-fiber technique:  
 Small hollow fibers (tubes 1mm in diameter and 2cm long made of plastic, 
polyvinylidene flouride), containing cells from human tumors are inserted underneath 
the skin and in the body cavity of the mouse. Each candidate drug is administered at 
two dosages and is tested against 12 target tumor cells in different hollow fibers. A 
total of about 20 compounds per week are screened by this method. Compounds that 
retard the growth of the cells are recommended for the next level of testing. The 
average length of this test is four days. 
Nude mouse model:    
Nude mice have been widely used to test the tumorogenicity of cells or for 
testing of anticancer drugs. These mice are immunologically incompetent because of 
absence of thymus. They neither show mitotic response in mixed lymphocyte 
reaction, nor generate cytotoxic effector cell. Lack of helper T and suppressor T cells 
alters the antibody response of the animals to antigen. They do not show contact 
sensitivity and do not reject the transplanted material. They are required to be 
maintained under strictly sterile conditions and in a warm environment (26-280). 
Some other points regarding their use are: 
a. Certain tumors like melanomas and colon carcinomas grow very well in nude 
mice, whereas prostate carcinoma and most types of leukemia grow very 
poorly. 
b. Large numbers of cells, usually >106 are required to be inoculated beneath the 
skin to get a successful tumor take. 
c. Metastases are rarely observed. 
d. Overall maintenance is very expensive. 
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1.5 INVIVO METHODS FOR SCREENING OF NEW ANTICANCER 
MOLECULES16: 
 
Studies that are in vivo (Latin for "within the living"; often not italicized in 
English) are those in which the effects of various biological entities are tested on 
whole, living organisms, usually animals, including humans, and plants as opposed to 
a partial or dead organism. 
 
USE  
  In vivo testing is necessary for medical and research purposes 
 The medical field benefits from animal models to test the safety of drugs 
before they are used on patients 
 The research field benefits from in vivo testing by validating in vitro findings 
in vertebrates closest to humans 
 In vivo testing using animal models of disease help discover new ways of 
solving complex health problems. 
METHODS  
 Xenograft  
 Spontaneous  
 Carcinogen-Induced  
 GEMs (Genetically Engineered Mouse models) 
 Transgenic  
 Knockout  
 Regulatable transgenic 
Xenograft Models of Cancer  
 Human cell lines in Immunocompromised mouse  
 Human tumor grafts in Immunocompromised mouse  
 Mouse cell lines in syngeneic host  
 Mouse tumor grafts in syngeneic host. 
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Subcutaneous Implantation 
Implant cells or tissues under the skin. 
Advantages  
 external monitoring of growth   
 easy & most commonly used human cells  
 Disadvantage  
 suboptimal vascular site  
 poor take rate  
 can be difficult to find tissue that does not grow into a tumor  
 can be an irritant to the anima. 
Spontaneous Models  
 Some strains of laboratory animals are susceptible to spontaneously developing 
certain types of tumors. 
Advantages  
 May mimic some types of human diseases  
 Can use to study early disease  
 Can use for prevention  
 Includes elements of  progression  
Disadvantages  
 Variability of disease progression  
 Large animal numbers needed  
 Long time to develop disease  
  Penetrance (Not all animals get disease) 
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Carcinogen-Induced  
  Animal is treated with a carcinogen to induce cancer.Some laboratory animal 
Strains are more susceptible. 
Examples include:  
 Lung cancer  
 Skin cancer  
 Bladder cancer  
 Stomach cancer  
 Prostate cancer 
Advantages  
 Mimics initiation steps of some cancer  
 Can study early events  
 Used to id predisposing conditions  
 Can study prevention  
Disadvantages  
 Health hazard to investigator  
 Variability of disease progression  
 Can require large animal numbers  
 Penetrance (all animals may not get disease) 
Genetically Engineered  Mouse (GEM) Models  
Simple Transgenic Models  
 Tissue specific promoter  
 Overexpression of gene  
 Ectopic expression (inappropriate expression)  
 Oncogene 
 Growth factor  
 Activated signaling molecules  
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 Dominant Negative molecules  
  Cell cycle regulators Endogenous gene is intact. 
Advantages  
 May mimic initiation steps of  some cancer  
 Can study early events  
 Can test genetic lesion that predispose  
 Autochthonous (rising in the tissue of origin)  
 Penetrance usually 100%  
 Immune system intact  
 Can progress with time  
Disadvantages  
 Variability of disease progression  
 Often requires large animal numbers  
 Initiator may be artificial  
 Time consuming to characterize & validate  
 Expression influenced by site of integration  
 May produce chimeric offspring  if integrated later in  
development. 
Knockout Models 
Approaches:  
 Homologous recombination  
 Cre-Lox system to KO in a tissue specific manner 
 Dominant Negative Transgenic (Functional KO)  Disrupts the endogenous 
gene 
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Inducible Systems   
 Requires a drug or hormone to induce gene expression 
 Can be used with Cre to obtain a  regulated knockout  
Examples include:  
 Tet On/Off (Tetracycline)  
 RU486 (Progesterone)  
 Ecdysone (Insect steroid hormone) 
Ideal Inducible System 
 Tightly regulated  
 Not leaky- low basal level  
 Induce to high level of expression  
 Induce only in presence of inducer  
 Induce nontoxic  
 Nonphysiological- not affect expression of  endogenous genes  
 Reversible expression. 
Advantages  
 Control when gene is expressed  
 Can rescue an embryonic lethal gene  
 Allows for normal development of the organ  
Disadvantages  
 Requires bi-or trigenics to get tissue specific expression  
 Large breeding program  
  Expensive 
 Can be dependent on expression level of regulator 
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1.6 SIGNIFICANCE OF THE PLANTS CHOSEN FOR THE PRESENT 
STUDY: 
The  plant Plumeria acutifolia Poir was reported that, it have a rich amount of 
Flavanoids18  mainly  phenolic compound  Gallic acid , Terpenoids, tannins, sterols 
(β-sitosterol,  β-sitosterol-3β  -D-  glucoside), triterpenes  (nonacosane  &  
hentriacontane) and saponins (sapogenins)19.  
 
1.7 SIGNIFICANCE OF THE DALTON’S LYMPHOMA ASCITES TUMOR 
CELL LINES (DAL) CHOSEN FOR THE PRESENT STUDY: 
1.7.1 Dalton’s lymphoma ascites tumor cell lines (DAL): 
 It is a tumor cell line originally grown from a tumor of the thymus.  
 It is propagated by growing as ascites tumor in mice.  
 We can induce both ascites tumor and solid tumors using DAL cells. 
 It is easy to maintain in vivo. 
 It is not an immunogenic. 
1.7.2 Maintenance of cell lines:  
Tumor Cell Line and Their Maintenance, Dalton’s lymphoma ascites tumor 
cell lines (DLA), originally obtained from Amala Cancer Institute, Thrissur, Kerala 
were propagated as transplantable tumors in the peritoneal cavity of the mice were 
used for the study. The tumor cell lines were maintained by serial peritoneal cavity i.p 
transplantation in mice. Full-grown tumor cell-line were aspirated mouse by injecting 
PBS in to peritoneal cavity make cells to suspend in  PBS, take that suspended 
solution  and count the number of  cells present in one ml by using tryphan blue 
exclusion method and adjust the cell count to 1×106 by using PBS were  inject 
intraperitonially in to a new healthy mouse. 
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2.REVIEW OF LITERATURE 
1. vijaya lakshmi.A, et.al., 2014., reported  pharmacognostic phytochemical 
investigation of the root bark of plant plumeria acutifolia  showing qualitative 
and quantitative phytochemical constituents. 
2. Akihiko omata et.al., 1992, evaluate the essential oil of plumeria rubra forma 
acutifolia. poir woodson cv. Common yellow growing in hawai was extracted 
by simultaneous distillationand extraction  (SDE).the essential oil was 
analysed with GC and GC-MS and total 74 compund were identified.  
3. A.vijayalakshmi et.al., 2011,studied that the Anti anaphylactic and anti 
inflammatory activities of a bio active alkaloid from the root bark of plumeria 
acutifolia poir. A dose dependent benificial effect was observed on leakage of 
evans blue dye in skin changed with antigen and on paw anaphylaxis indused 
by antiserum . 
4. surendra kr sharma, et.al., 2012, assayed Anti microbial potential of plumeria 
rubra syn plumeria acutifolia bark were sucessive extracts of plumeria rubra 
syn plumeria acutifolia using petrolium ether (60-70°C) chloroform methanol 
and water. finally reported as plant having anti microbial action. 
5. Jeriel naomi B bacer,et al 2017,reported the chemical investigation of dichloro 
methane extract of the white flower of plumeria rubra. L.syn plumeria 
acuminata (W.T.aiton) affored a mixture of lupeol (1) amyrin (2) amyrin (3) 
in about 8:2:1 ratio.the structure of 1-3 were identified by comparison of their 
NMR data with those reported in the literature.  
6. Aidroo M.hasant, et.al., 1997, were investigated species of genus plumeria 
have been investigated for iridoids and triterpenoid and some of these have 
been found to exhibit algicidal, antibacterial cytotoxic and plant grow 
inhibiting activity.bioassay result of plumeria acutifolia indicate that the ccl4 
extract has antimutagenic activity . 
7. nihon yakugakkai. 1988, reported Six new iridoids i.e 13-o caffeoyl 
plumieride, 13- deoxy plumieride, 13- dihydro plumericinic 
acid,glucosylester, 1 alpha plumieride , 1 alpha proto plumiericin A, etc were 
isolated from polar fraction of the methanol percolate of the root of plumeria 
acutifolia.and the presence confirms the plant have antioxidant activity. 
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8. pradeep kumar R,2014, analysed Plumeria acutifolia lactase is used for mouth 
ulcer were studied in ethonochemical survey on plants used by tribal in chitteri 
hills. 
9. Traditional healing practise in north east india were studied various medicinal 
plants healing activity.they mentioned their article about plumeria acutifolia 
have antifertility activity. 
10. nylane maria nunes de alencar et.al., 2015,  were reported Plumeria rubra 
(Apocynaceae) is frequently used in folk medicine for the treatment of 
gastrointestinal disorders,hepatitis and tracheitis among other infirmities. 
Investigate the gastroprotective potential of a protein fraction isolated from the 
latex of plumeria rubra (prlb) against ethanol -induced gastric lesions. 
11. zahid zaheer et.al., 2010, are studied Plumeria rubra used to treat asthma,ease 
constipation promote mensturation,venerial disease reduce fever and latex 
used to soothe irritation. The plant contains phyto constituents like cytotoxic 
iridoids, fulvoplumerin,oleanane type triterpene. 
12. umakant sharma, et al 2011,were analysed the genus plumeria apocynaceae is 
known as a source of iridoids. is this study chloroform extract prepared from 
the bark of this plant showed significant anti leishmanial activity 
13. Gupta M et.al.,2006, reported that the methanol extract of Plumeria acuminata 
leaves exhibited significant anti-inflammatory activity on the tested 
experimental animal models. Administration of EPA (500 mg/kg b.w) and 
indomethacin (10 mg/kg b.w) significantly reduced the formation of 
granuloma tissue induced by cotton pellet method at a rate of 45.06 and 
51.57% respectively30. They also studied the anti oxidant activity of the 
Plumeria acuminata leaves1. 
14. Amelia P.  Guevara et.al., 2012, were studied anti mutagenic activityof the  
ethanol  extract  of  the  green  leaves  of  Plumeria acuminata  Air. The  
antimutagens  were  isolated  from  the  bioactive  hexane  and  carbon  
tetrachloride  fractions  following a bioactivity-directed  fractionation scheme 
and using  the micronucleus test to monitor the antimutagenic activities2. 
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15. Rasool S. et.al., 2008, studied the Antimicrobial activities of Plumeria 
acutifolia Poir. Ethanolic extract ofstem bark was tested for antimicrobial 
activity against Gram-positive bacteria, Gram-negative bacteria and fungi by 
disc diffusion method3. 
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Figure.4 Plumeria acutifolia Poir 
3.1 BOTANICAL CLASSIFICATION:  
  Kingdom  :  Plantae  
  Division  : Magnoliophyta 
  Class   : Magnoliopsida 
  Subclass  :  Asteridae 
  Order   :  Gentianales 
  Family   : Apocynacea         
Botanical name : Plumeria acutifolia poir                                
                                                      
3.2 COMMON NAMES: 
  English  : Temple tree 
  Hindi   :  Gulachin, Golainchi 
  Telugu   : Vaada Ganneru, Deva Ganneru 
  Tamil   : Atralari 
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3.3DESCRIPTION: 
 Small tree, 3 to 7 m high, stem smooth and shining, succulent, with abundant 
white latex; easily breaks. 
 Leaves: crowded at the terminal end of the branch, commonly oblong in 
shape, reaching a length of 40 cm and a width of 7 cm.  
 Flowers: fragrant, the upper portion whitish, while the inner lower portion 
yellow, 5 – 6 cm long.  
 Fruits: linear-oblong or ellipsoid follicles. 
3.4 MEDICINAL USES 
 Decoction of bark is used as purgative. 
 Used in Prevention of heat stroke: the material may be taken as a cooling tea. 
 For dysentery, diarrhea during summer season: use 12 to 24 gms of dried 
material in decoction. 
 Arthritis, rheumatism, pruritic skin lesions: Mix the latex (sap) with coconut 
oil, warm, and apply to affected area. 
 Decoction of its bark is used as a counterirritant on the gums for toothache. 
 The latex mixed with coconut oil is used for itching. 
 The juice was used as rubefacient in rheumatic pains, and with camphor, is 
also used for itching. 
 A poultice of heated leaves is beneficial for swellings. 
 Decoction of leaves used for cracks and eruptions of the soles of the feet. 
 Infusion or extract from leaves is used for asthma. 
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4.AIM AND OBJECTIVE OF THE STUDY 
 The aim of the study is to evaluate the Anti Cancer activity. On the world 
wide basis cancer is the single largest cause of the death both in man and women. 
Therefore the challenging task at this moment is to identify the quick and novel 
methods that can identify and develop molecules, which can be of therapeutic value in 
human cancer. 
India has long tradition of the use of drugs, derived from plant sources. 
Nowadays even the allopathic specialists are also started to move into Ayurvedic, 
Siddha and Unani system of treatment in western countries, to avoid the untoward 
effects of certain allopathic medicines, though they are much potent. This indicates 
that there will be a much better scope for the natural plant sources, which will have a 
therapeutic value.  
The present synthetic cancer drugs produce undesirable side effects and 
treatment is cost effective. At the same time plant derived anticancer molecules are 
safer and potent. So in this present study, plant source was selected. 
 The plants selection in the present study was done on basis of it easy 
availability and phytochemical constituents to screen their therapeutic potential. The 
plant Plumeria acutifolia Poir contain alkaloids, flavonoids, steroids, phenol and other 
constituents. Flavonoids and phenol compounds plays main role in free radical 
scavenging. 
Hence an effort was made to explore the exploited properties of the plants, its 
active constituents and their role in cancer.  
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5.PLAN OF WORK 
Phase I:  
5.1. Phytochemical studies: 
 Collection and authentication of plants. 
 Extraction of plant material by using a suitable solvent system. 
 Preliminary phytochemical study for the identification of plant secondary 
constituents. 
Phase II:  
5.2. Pharmacological studies: 
 Evaluation of anticancer activity of ethanol extract of leaf of plumeria acutifolia  
     (EPA) against Dalton’s Ascites Lymphoma (DAL) in mice. 
 Evaluation of antioxidant enzymes and its parameters with special reference to 
cancer cell lines. 
 Histopathological study of mice liver tissue 
Phase III:  
5.3 Statistical Analysis 
The data’s were presented as mean ± SEM and were subjected to statistical 
analysis by Dunnett’s test followed by one way ANOVA. P-value less than 0.05 were 
considered statistically significant 
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6.MATERIALS AND METHODS 
6.1 MATERIALS 
6.1.1 COLLECTION AND AUTHENTICATION OF PLANTS: 
 The plant materials were collected in the month of July from chinesepet of 
Salem district and the plants were authenticated by Dr. G.V.S. MURTHY, scientist F, 
the Botanical Survey of India, Coimbatore.  
6.1.2  EXTRACTION PROCESS: 
 The plants leaves were shade dried and made into coarsely powder. The 
powder was packed into the soxhlet extractor. The fatty matter was removed by 
petroleum ether and the active constituents were extracted by using ethanol until the 
powder gets decolorized. The extract was concentrated by distillation and stored for 
screening its activity. 
6.1.3 ANIMAL USED: 
 Inbred female Swiss mice of 2 months age, weighing 20 ± 5 g, were purchased 
from Govt veterinary college Mannuthi, Thrissur, India, were used for the study. The 
mice were obtained from the stock in breed colony, which was maintained by mating 
brothers and sisters. They were housed at room temperature of 22◦C under 12 hr 
light/12 hr dark cycle in the animal house. Mice were fed with commercial pellet diet 
and water ad libitum freely throughout the study. All animal procedures were 
performed after approval from the IAEC (institution of animal ethical committee) and 
in accordance with the recommendations for the proper care and use of laboratory 
animals. 
6.1.4 DETERMINATION OF ACUTE ORAL TOXICITY  
Test Substance Details 
Name of the test substance …..extract 
Colour of the test substance Dark orange 
Nature of the test substance Sticky  
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Experimental Protocol 
Name of the study  Acute toxicity 
Guideline followed OECD 423 method – acute toxic class 
method 
Animals    Healthy young adult Swiss Albino Mice, 
nulliparous, non-pregnant 
Body weight   25-30 g 
Sex  Female 
Administration of dose and volume 2000 mg/kg body weight, single dose in 
0.5 ml 
Number of animals Two groups each consist of 3 animals. After 24h observation of first group animals, second group animals 
was dosed and both the group of animals was observed 14 days for the toxicity sign. 
Route of administration Oral by using mice oral needle  
Vehicle         0.2%  propylene glycol 
Housing and Feeding Conditions 
Room temperature   22o C ± 3o C 
Humidity    40 – 60 % 
Light     12 h :12h (light : dark cycle) 
Feed Standard laboratory animal food pellets 
with water ad libitum 
                                                                                                                                                        
Study Period and Observations Parameters 
Initial once observation First 30 minutes and periodically 24 h 
Special attention First 1–4 h after drug administration 
Long term observation Up to 14 days 
Direct observation parameters Tremors, convulsions, salivation, 
diarrhea, lethargy, sleep and coma. 
Additional observation parameters Skin and fur, eyes and mucous 
membrane, respiratory, circulatory, 
autonomic and central nervous systems, 
somatomotor activity and behavior 
pattern etc. 
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The time of death, if any, is recorded. (Complete observations: Annexure I). 
After administration of the drug, food is withheld for a further 1 – 2 hours. 
 Study Procedure 
            Acute oral toxicity study was performed as per Organization for Economic 
Cooperation and Development (OECD) guideline 423 method. The test substance was 
administered in a single dose by gavage using specially designed mice oral needle. 
Animals are fasted 3 h prior to dosing (food was withheld for 3 h but not water). 
Following the period of fasting animals was weighed and test substance was 
administered. After the test substance administration, food was with held  2 h in mice. 
Animals are observed individually after dosing at least once during the first 30 
minutes, periodically during the first 24 hrs, with special attention given during the 
first 4 hrs, and daily thereafter, for a total of 14 days. Animals are removed, if any 
humanely killed for animals welfare reasons or are found dead. All the observations 
are systemically recorded and given in annexure. 
  
 
 
 
 
 
Figure 5.Haemocytometer 
6.1.5.EXPERIMENTAL DESIGN 
DAL-INDUCED ASCITIC ANTITUMOR MODEL (1) 
a)  ADJUST CELL COUNT TO 1×106 cells: 
Requirements: 
a) Ehrlich ascites carcinoma (EAC) 
b) Phosphate buffer saline solutions 
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c) Haemocytometer 
d) Tryphan blue solution (0.4%) 
 
Method: 
0.5ml of 0.4% Tryphan blue, 0.3ml of PBS and 0.2ml of cell suspension were 
mixed and kept aside for 5min and not more than 15min. From this one drop of 
solution was taken on a neubar chamber and a cover slip is placed. This is placed on 
Haemocytometer and the viable and non-viable cells were counted under 10X power. 
Viable cells doesn’t take colour and these cells appear in white colour on blue 
background Non-viable cells(dead cells) take blue colour and give dark blue shading 
to the cells, cell count was calculated using formula. 
Cell count = No. of cells x Dilution factor × volume fact 
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                                              Figure.6  experimental design 
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b)  DAL-induced ascitic antitumor model: 
The anti tumor activity of the EXT was determined by injecting DAL cell 
suspension (1×106 cells per mouse) in to the peritoneal cavity of the animals and 
treatment was started after 24 hours of the tumor inoculation continued once daily for 
14 days and the antitumor efficacy of test sample was compared with that of 5-Fu 
(20mg/kg, i.p) and DAL control.  
 
6.2 METHODS 
6.2.1 PRELIMINARY PHYTOCHEMICAL ANALYSIS39: 
CHEMICAL TESTS: 
  A) TEST FOR CARBOHYDRATES: 
1) Molisch Test: In this a small amount of test extract is treated with -naphthol 
and concentrated sulphuric acid along the sides of the test tube. Purple colour 
or reddish violet color at the junction between two liquids was formed. It 
indicates presence of carbohydrates.  
2) Fehling’s Test: In this small amount of test extract is treated with Equal 
quantity of Fehling’s solution A and B is and Heat gently, brick red 
precipitate was formed. It indicates presence of carbohydrates.  
3) Benedict’s test: To the 5 ml of Benedict’s reagent, added 8 drops of 
extraction solution. Mixed well, boiling the mixture vigorously for two 
minutes and then cool. Red precipitate was formed. It indicates presence of 
carbohydrates.  
4) Barfoed’s test: To the 5 ml of the Barfoed’s solution added 0.5 ml of 
extraction solution and mixed well and heated to boiling, red precipitate was 
formed. It indicates presence of carbohydrates.  
B) TEST FOR ALKALOIDS 
1) Dragendroff’s Test: To the extract, 1 ml of Dragendroff’s reagent was added 
Orange red precipitate was formed. It indicates presence of alkaloids.  
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2) Wagner’s test: To the extract Wagner reagent was added. Reddish brown 
precipitate is formed it indicates presence of alkaloids.  
3) ) Mayer’s Test: To the extract added 2 ml of Mayer’s reagent. Dull white 
precipitate was produced.  It indicates presence of alkaloids.   
4)  Hager’s Test: To the extract added 3 ml of Hager’s reagent yellow 
Precipitate is produced. It indicates presence of alkaloids.   
C) TEST FOR STEROIDS AND STEROLS 
1) Libermann Burchard test: In this test sample is dissolved in 2 ml of 
chloroform in a dry test tube. Then added10 drops of acetic anhydride and 2 
drops of concentrated sulphuric acid. The solution becomes red, then later it 
was not changed to blue and bluish green colour it indicates absence of 
steroids and sterols.   
2) Salkowski test: In this the test sample was dissolved in chloroform and adds 
equal volume of conc. sulphuric acid. Bluish red cherry red and purple color is 
not formed in chloroform layer, and also green fluorescence was not formed 
indicate absence of steroids and sterols. 
D) TEST FOR GLYCOSIDES 
1) Legal’s test: The extract Sample is dissolved in pyridine sodium nitropruside 
solution is added to it and made alkaline. Pink red color is produced. Indicate 
presence of glycosides. 
2)  Baljet test: To the extract sample, sodium picrate solution is added. Yellow 
to orange colour is produced. Indicate presence of glycosides. 
3) Borntrager test: Add a few ml of dilute sulphuric acid to the test solution. 
Boiled, filtered and extract the filtrate with ether or chloroform. Then organic 
layer is separated to which ammonia is added, pink, red or violet colour is 
produced in organic layer. Indicate presence of glycosides.  
4) Killer Killen test: Sample is dissolved in acetic acid containing trace of ferric 
chloride and transferred to the surface of concentrated sulphuric acid. At the 
junction of liquid reddish brown color is produced which gradually becomes 
blue. Indicate presence of glycosides. 
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E) TEST FOR SAPONINS 
Foam test: About 1 ml of alcoholic sample is diluted separately with distilled 
water to 20 ml and shacked in graduated cylinder for 15 minutes. 1 cm layer of foam 
was formed it indicates the presence of saponins. 
F) TEST FOR FLAVANOIDS 
Shinoda test: To the sample magnesium turnings and then concentrated 
hydrochloric acid is added. Red color is produced. Indicate the presence of flavanoids. 
G) TEST FOR TRITERPENOID 
 In the test tube, 2 or 3 granules of tin was added, and dissolved in a 2ml of 
thionyl chloride solution and test solution was added. Pink color is produced which 
indicates the presence of triterpenoid. 
 H) TEST FOR PROTEIN AND AMINO ACID 
1) Biuret test:  Added 1 ml of 40% sodium hydroxide and 2 drops of 1% copper 
sulphate to the extracts, a violet colour formed indicates the presence of 
proteins. 
2) Ninhydrin test:  Added 2 drops of freshly prepared 0.2% ninhydrin reagent 
to the extracts and heated. A blue colour developed indicating the presence of 
proteins, peptides or amino acids. 
3) Xanthoprotein test: To the extracts, added 20% of sodium hydroxide. 
Orange colour was formed indicates presence of aromatic amino acid. 
6.2.2 DETERMINATION OF BODY WEIGHT AND SURVIVAL TIME  
Body weight analysis: 
 All the mice were weighed for every five days, after tumor inoculation. 
Average gain in body weight was determined and a % decrease in body weight was 
calculated by the formula. 
%Decrease in body weight = (Decrease in body weight/initial body weight) ×100 
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Mean Survival Time (MST): 
After induction every day checks all the groups for mortality & record how 
many days the mouse is survived the mean survival time (MST) and percentage 
increase in life span (ILS %) was calculated by using the formula. 
Mean survival time = [1st Death + Last Death] / 2 
     
ILS (%) = [(Mean survival of treated group/ Mean survival of control group)-1] x100 
 
6.2.3 DETERMINATION OF HEMATOLOGICAL & IN VIVO-
ANTIOXIDANT 
 Viable and non-viable cell count: 
Requirements: 
a) Daltons ascites lymphoma(DAL)  
b) Phosphate buffer saline solutions 
c) Haemocytometer 
d) Tryphan blue solution (0.4%) 
 Method: 
After 14 days treatment animals are slightly anaesthetized with diethyl ether 
from the intraperitonial cavity of mice take 0.2ml of cell suspension were mixed with 
0.5ml of 0.4% Tryphan blue, 0.3ml of normal saline or PBS and kept aside for 5min 
and not more than 15min. From this one drop of solution was taken on a neubar 
chamber and a cover slip is placed. This is placed on Haemocytometer and the viable 
and non-viable cells were counted under 10X power Viable cells doesn’t take colour 
and these cells appear in white colour on blue background Non-viable cells(dead 
cells) take blue colour and give dark blue shading to the cells, cell count was 
calculated using formula . 
Cell count = No. of cells x Dilution factor × volume factor 
 
 
Department of Pharmacology                     36                    J.K.K.Nataraja College of Pharmacy 
 
 
Preparation of Blood Serum and Tissue Samples for The Bio Chemical Studies: 
  After 14 days treatment the animals were fasted over night and collect the 
blood sample and intraperitonial fluid by mild anaesthised the mice with diethyl ether 
and then sacrificed by cervical dislocation. Blood was collected for estimation of 
RBC, WBC, Hb percentage.  
Tissues like liver was removed from the mouse body and tissues were 
transferred to ice cooled containers. Wiped thoroughly using blotting paper to remove 
blood and other body fluids then they were washed in normal saline, again wiped 
desired amounts of dried tissues were used for various biochemical analysis and 
histopathology studies .  
 Estimation of Hematological Parameters: 
A) Enumeration of white blood cells:2,3 
The total white blood cells were enumerated according to the method of John 
(1972) 
Reagents: 
Turk’s fluid (WBC diluting fluid). 
Procedure: 
Using a white blood cell pipette of haemocytometer, well mixed blood was 
drawn up to 0.5 mark and WBC diluting fluid was taken up to mark II. The fluid 
blood mixture was shaken and transferred onto the counting chamber. The cells were 
allowed to settle to the bottom of the chamber for 2 min. See the fluid does not get 
dried. 
Using 10X or low power objective the WBC’s were counted uniformly in the 
larger corner squares.  
The cells were expressed as number of cells x109/L  
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B) Enumeration of red blood cells: 
Reagents: RBC diluting fluids 
Procedure: 
Using a red blood cell pipette of haemocytometer, well mixed blood was 
drawn up to 0.5 mark and RBC diluting fluid was taken up to mark II. The fluid blood 
mixture was shaken and transferred onto the counting chamber. The cells were 
allowed to settle to the bottom of the chamber for 2 min. See the fluid does not get 
dried. Using 45X or high power objective the RBC’s were counted uniformly in the 
larger corner squares.   
The cells were expressed as number of cells x1012/L or x 106 / cu.mm 
C)  Differential Leukocyte Count: 
Differential Leukocyte count was determined by the method of John (1972). 
Reagent: 
              Leishmann’s stain: 150mg of powdered leishmann’s stain was dissolved in 
133ml of acetone free methanol. 
Procedure: 
A blood film stained with leishmann’s stain was examined under oil 
immersion and the different types of WBCs were identified. The percentage 
distribution of these cells was then determined. Smears were made from anticoagulant 
blood specimens and stained with leishmann’s stain. The slides were preserved for 
counting the number of lymphocytes and neutrophils, per 100 cells were noted.  
The number of neutrophils was expressed as (%) 
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D) Estimation of Hemoglobin: 
Sahli’s acid haematin method: 
Principle: 
Haemoglobin is converted into acid haematin by the action of HCl. The acid 
haematin solution is further diluted with distilled water until its colour matches with 
exactly that of permanent standard of comparator block. The Hb concentration is read 
directly from the calibration tube. 
Requirements: 
HCl solution, sahli’s Hemoglobinometer, pipette, distilled water. 
Procedure: 
       By using pipette add 0.1 N HCl in the Hemoglobinometer up to the lowest 
marking. 20µl of blood was drawn up to 20µl in the sahli’s pipette. Adjusted the 
blood column carefully without bubbles. Wiped the excess of blood on the sides of 
the pipette by using a dry piece of cotton. Blown the blood into the acid solution in 
the graduated tube, rinsed the pipette well. Mixed the reaction and allow the mixture 
to stand at room temperature of 10 minutes. Diluted the solution with distilled water 
by adding few drops of water carefully and by mixing the reaction mixture until the 
colour matches the colour in the comparator. The lower meniscus of the fluid was 
noted and reading was noted in g/100ml. 4. 
6.2.4 SERUM BIO CHEMICAL PARAMETRES 
The separated serum was used for estimation of alkaline phosphatase    ALP), 
Serum glutamic oxaloacetic transaminase    SGOT) and serum glutamic pyruvic 
transaminase    SGPT), serum creatinine and protein by using semi auto analyzer    
Photometer 5010 v5+)using standard  enzymatic kits procured from Piramal 
Healthcare limited, Lab Diagnostic Division, Mumbai, India. 
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 ESTIMATION OF SGOT: Serum glutamate oxalo acetate transaminase ( SGOT) 
Principle: 
L-Aspartate + 2-Oxaloglutarate      ASAT        L-Glutamate + Oxaloacetate 
Oxaloacetate + NADH + H⁺     MDH        D-Malate + NAD⁺ 
Addition of pyridoxal-5 phosphate    P-5-P) stabilizes the transaminases and 
avoids falsely low values in samples containing insufficient endogenous P-5-P, e.g. 
From patients with myocardial  infraction, liver diseases and intensive care patients.    
Table.3 Reagents  
 
Method: 
Optimized UV- test according to IFCC   International Federation Of Clinical 
Chemistry and Laboratory Medicine). 
 
R 1 TRIS pH 7.8 80  mmol/l 
L- Aspartate 240 mmol/l 
MDH    malate dehydrogenase) ≥600 U/l 
LDH    lactate dehydrogenase) ≥600 U/l 
R 2 2-Oxaloglutarate 12 mmol/l 
NADH 0.18 mmol/l 
Pyridoxal-5-phosphate FS  
Good buffer pH 9.6 0.7 mmol/l 
Pyridoxal-5-phosphate 0.9 mmol/l 
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Assay procedure: 
a) Mixed  800 µl of reagent-1 with 200 µl of reagent-2 in a 5 ml test tube. 
b) To this, added 100 µl of serum. 
c) Mixed well and took the  reading immediately. 
Clinical significance:  
AST Occurs in all human tissue and is present in large amounts in liver, renal 
cardiac and skeletal muscle tissue. 
Increases:  
increased levels are associated with liver disease or damage, myocardial 
infarction, cholecystitis. 
Decreases: 
 decreased levels are observed in patient undergoing renal dialysis and those 
with vitamin B 6 deficiency. 
Reagent composition: 
when reconstituted as directed) 
Normal Range: < 41 U/l 
 ESTIMATION OF SGPT:  
Serum glutamate pyruvate transaminase (SGPT): 
Principle: 
L-Alanine +2-oxoglutarate       ALAT        L-Glutamate + Pyruvate 
Pyruvate + NADH + H⁺        LDH         D-Lactate + NAD⁺ 
  Addition of pyridoxal-5-phosphate    P-5-P) stabilizes the transaminases and 
avoids falsely low values in samples containing insufficient endogenous P-5-
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P,eg.from patients with myocardial infarction, liver diseases and intensive care 
patients. 
Method: 
Kinetic UV test, according to the International federation of clinical chemistry 
and laboratory medicine    IFCC). 
Table.4  Reagents  
 
 
 
 
 
 
 
 
Normal range: < 41 u/l 
Clinical significance:  
ALT is present in high concentration in liver and to a lesser extent in kidney, 
heart, skeletal muscle, pancreases, spleen and lungs. 
Increases: 
 Increased levels are generally resulting of primary liver disease such as 
cirrhosis’s carcinoma, viral or obstructive jaundice. 
 
R 1 
TRIS pH 7.5 100  mmol/l 
L- Alanine 500 mmol/l 
LDH    lactate dehydrogenase) ≥ 1200 U/l 
R 2 
2-Oxoglutarate 15 mmol/l 
NADH 0.18 mmol 
Pyridoxal-5-phosphate FS  
Good buffer pH 9.6 0.7 mmol/l 
Pyridoxal-5-phosphate 0.9 mmol/l 
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Decreases:  
decreased levels may be observed in renal dialysis patients and that vitamin 
B6 deficiency. 
 ESTIMATION OF SERUM ALKALINE PHOSPHATASE  (ALP):  
Alkaline phosphatase (ALP), and hydrolytic enzyme act optimally at an 
alkaline pH. They are present in blood in numerous distinct forms which originate 
mainly from bone and liver                                                                         
p-Nitro phenyl phosphate +water   ALP         Phosphate + p-Nitro phenol 
Kinetic photometric test, according to the international Federation of clinical 
chemistry and laboratory Medicine    IFCC) 
Table.5  Reagents   
Reagent 1 : Concentration 
2-Amino-2-methyl-1-propanol 
pH 10.4 
0.35 mol/l 
Magnesium sulphate 2.0 mmol/l 
Zinc sulphate 1.0mmol/l 
HEDTA 2.0 mmol/l 
Reagent 2 : Concentration 
p-Nitrophenylphosphate 16.0mmol/l 
 
Assay method: 
1. Taken 1000 µl of reagent-1 in a 5 ml test tube 
2. To this added 250 µl of reagent-2 and mixed well 
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3. Add 20 µl of serum and mix well and take reading immediately using a 
photometer.   
4. Normal range: 53-128 µ/l.    Soldin et.al., 1996) 
Principle: 
Under alkaline condition, colorless p-nitrophenol is converted to 4 
nitrophenoxide, which develops a very intense yellow color.  Its intensity is 
proportional to the activity of alkaline phosphatase in the sample.  
P-Nitro-phenylphosphate + H2O   ALP>   p-Nitrophenol + Phosphate 
Clinical Significance : 
ALP is present in high concentrations in liver, bone, placenta intestine and 
certain tumors  Increases  
Normal:  
Physiologically elevated serum alkaline phosphatase occurs in pregnant 
women and in pregnant women and in growing children.  
Pathological: 
 Increased levels of the enzyme occur in liver diseases, bone diseases    
Rickets, Paget’s Disease), Hodgkin’s disease or congestive heart failure.  
Decreases : 
Decreased levels occur in hypophosphatasia and malnourished patients.  
 ESTIMATION OF SERUM BILIRUBIN:  
Principle : 
Bilirubin reacts with diazotized sulphanilic acid in acidic medium to form pink 
colored azobilirubin with absorbance directly proportional to Bilirubin concentration.  
Direct Bilirubin, being water soluble directly reacts in acidic medium.  However 
indirect or unconjugated Bilirubin is solubilised using a surfactant and then it reacts 
similar to Direct Bilirubin.  
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Clinical Significance:   
Bilirubin is a breakdown product of haemoglobin.  Bilirubin formed in the 
reticulo-endothelial system is transported to the liver bound to albumin.  This 
bilirubin is water insoluble and is known as indirect or unconjugated bilirubin.  In the 
liver, bilirubin is conjugated to glucuronic acid to form direct bilirubin.  Conjugated 
bilirubin is excreted via the bilary system into the intestine where it is metabolized by 
bacteria to urobilinogen and stercobilinogen.  
Total Bilirubin = Indirect Bilirubin + Direct Bilirubin 
Increases : 
Total Bilirubin is elevated in obstructive conditions of the bile duct, hepatitis, 
cirrhosis, in hemolytic disorders and several inherited enzyme deficiencies.  
Indirect Bilirubin is elevated by pre-hepatic causes such as hemolytic 
disorders or liver diseases resulting in impaired entry, transport or conjugation within 
the liver.  Monitoring of direct bilirubin in neonates is of special importance as it is 
the indirect    or free) bilirubin bound to albumin that is able to cross the blood brain 
barrier more easily, increasing the danger of cerebral damage.  
 
Table.6 Reagent Composition : 
Reagent 1: Total Bilirubin Reagent  
Surfactant  1.00% 
HCl 100 m mol/L 
Sulphanilic Acid 5 m mol/L  
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Reagent 2: Direct Bilirubin Reagent  
Sulphanilic Acid 10 m mol/L 
HCl 100 m mol/L 
 
Reagent 3: Sodium Nitrite Reagent  
Sodium Nitrite 144 m mol/L 
 
Assay Procedure: Allow the working reagent to attain 37 c performing the test. 
Pipette into test tubes 
marked 
Blank Standard Test 
Working Reagent  500 l 500 l 500 l 
Distilled Water 25 l - - 
Standard / Calibrator - 25 l - 
Test - - 25 l 
 
Mix well; incubate for 5 minutes at 37C for Total Bilirubin and Direct Bilirubin.  
Read Absorbance at 546/630 nm against reagent blank.  
 ESTIMATION OF TOTAL PROTEIN 
Estimation of Protein: 
 Protein was estimated by the method of Lowry et al.    1951). 
Reagents: 
1. Alkaline copper reagent 
 Solution A:  2% sodium carbonate in 0.1 N NaOH 
 Solution B: 0.5% copper sulphate in 1% sodium potassium tartarate 
50 ml of solution A was mixed with 1 ml of solution B just before use. 
2. Folin's phenol reagent    commercial reagent, 1:2 dilution) 
3. Bovine serum albumin (BSA). 
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Procedure: 
 To 0.1 ml of suitably diluted plasma/homogenate/hemolysate, 0.9 ml of water and 4.5 
ml of alkaline copper reagent were added and kept at room temperature for 10 min. 
Then 0.5 ml of Folin’s reagent was added and the colour developed was read after 20 
min at 640 nm. The level of protein was expressed as mg/g tissue or mg/dl.   
Normal Range: 6.6-8.7 gm/dl 
Determination of biochemical parameters 
For assessment of liver function, blood samples were collected from the 
animals by puncturing the retro-orbital plexus and centrifuged. The serum collected 
after centrifugation was analyzed for various biochemical parameters like SGOT, 
SGPT, ALP, TB and total protein (TP) (Lowry OH, Rosebrough NJ, Farr AL, Randall 
RJ, 1951.Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265.). 
Serum transaminase activity was measured according to the method of Rietman and 
Frankle. (Reitmann S, Frankel S, 1957.  
A colorimetric method for the determination of serum oxaloacetic and 
glutamic pyruvate transminases. American Journal of Clinical Pathology.28: 56-63). 
The ALP and the serum bilirubin was determined by using method of Kind. (Kind 
PRM, King EJ, 1972. In-vitro determination of serum alkaline phosphatase. Journal of 
Clinical Pathology 7: 321-22.) 
Determination of aspartate aminotransferase (AST) 
Aspartate aminotransferase, also known as Glutamate Oxaloacetate 
Transaminase (GOT) catalyses the transamination of L-aspartate and α keto glutarate 
to form oxaloacetate and L- glutamate. Oxaloacetate formed is coupled with 2,4- 
Dinitrophenyl hydrazine to form hydrazone, a brown coloured complex in alkaline 
medium which can be measured colorimetrically. 
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Reagents:  
Buffered aspartate  (pH 7.4); 2,4- DNPH reagent;  4N sodium hydroxide;  
working pyruvate standard; solution I (prepared by diluting 1 ml of reagent 3 to 10 ml 
with purified water). 
Procedure  
Rietman and Frankle method was adopted for the estimation of SGOT. 
(Reitmann S, Frankel S, 1957. A colorimetric method for the determination of serum 
oxaloacetic and glutamic pyruvate transminases. American Journal of Clinical 
Pathology.28: 56-63.The reaction systems used for this study included blank, 
standard, test (for each serum sample) and control (for each serum sample). 0.25 ml of 
buffered aspartate was added into all the test tubes. Then 0.05 ml of serum was added 
to the test group tubes and 0.05 ml of working pyruvate standard into the standard 
tubes. After proper mixing, all the tubes were kept for incubation at 37oC for 60 min, 
after which 0.25 ml each of 2,4- DNPH reagent was added into all the tubes. Then, 
0.05 ml of distilled water and 0.05 ml of each serum sample was added to the blank 
and the serum control tubes respectively. The mixture was allowed to stand at room 
temperature for 20 min. After incubation, 2.5 ml of solution I was added to all test 
tubes. Mixed properly and optical density was measured in a spectrophotometer at 
505 nm within 15 min. 
The enzyme activity was calculated as:-  
AST (GOT) activity in IU/L) = [(Absorbance of test - Absorbance of control)/ 
(Absorbance of standard - Absorbance of blank)] x concentration of the standard     
 Determination of alanine aminotransferase (ALT) 
Alanine aminotransferase, also known as Glutathione Peroxidase (GPT) 
catalyses the transamination of L-alanine and α keto glutarate to form pyruvate and L- 
Glutamate. Pyruvate so formed is coupled with 2,4 – Dinitrophenyl hydrazine to form 
a corresponding hydrazone, a brown coloured complex in alkaline medium which can 
be measured colorimetrically. 
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Reagents 
Buffered alanine (pH 7.4), 2,4–DNPH, 4N sodium hydroxide, working 
pyruvate standard, solution I (prepared by diluting 1 ml of reagent 3 to 10 ml with 
purified water). 
Procedure  
Rietman and Frankle method was dopted for the estimation of SGPT. The 
reaction systems used for this study included blank, standard, test (for each serum 
sample) and control (for each serum sample). 0.25 ml of buffered alanine was added 
into all the test tubes. This was followed by the addition of 0.05 ml of serum into the 
test group tubes and 0.05 ml of working pyruvate standard into the standard tubes. 
After proper mixing, all the tubes were kept for incubation at 37oC for 60 minutes, 
after which 0.25 ml each of 2,4- DNPH reagent was added into all the tubes. Then, 
0.05 ml of distilled water and 0.05 ml of each serum sample was added to the blank 
and the serum control tubes respectively. The mixture was allowed to stand at room 
temperature for 20 min. After incubation, 2.5 ml of solution I was added to all test 
tubes. Mixed properly and optical density was read against purified water in a 
spectrophotometer at 505 nm within 15 min. 
The enzyme activity was calculated as:- ALT (GPT) activity in IU/L) = 
[(Absorbance of test - Absorbance of control)/ (Absorbance of standard - Absorbance 
of blank)] x concentration of the standard.      
Determination of alkaline phosphatase (ALP) 
Alkaline phoshatase from serum converts phenyl phosphate to inorganic 
phosphate and phenol at pH 10.0. Phenol so formed reacts in alkaline medium with 4-
aminoantipyrine in presence of the oxidising agent potassium ferricyanide and forms 
an orange-red coloured complex, which can be measured spectrometrically. The color 
intensity is proportional to the enzyme activity. 
Reagents: 
 Buffered substrate 
 Chromogen Reagent 
 Phenol Standard, 10 mg% 
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Procedure: 
ALP was determined using the method of Kind (Kind PRM, King EJ, 1972. 
In-vitro determination of serum alkaline phosphatase. Journal of Clinical Pathology 7: 
321-22\). The working solution was prepared by reconstituting one vial of buffered 
substrate with 2.2 ml of water. 0.5 ml of working buffered substrate and 1.5 ml of 
purified water was dispensed to blank, standard, control and test. Mixed well and 
incubated at 370C for 3 min. 0.05 ml each of serum and phenol standard were added 
to test and standard test tubes respectively. Mixed well and incubated for 15 min at 
370C. Thereafter, 1 ml of chromogen reagent was added to all the test tubes. Then, 
added 0.05 ml of serum to control. Mixed well after addition of each reagent and the 
O.D of blank, standard, control and test were read against purified water at 510 nm. 
Serum alkaline phosphatase activity in KA units was calculated as follows 
[(O.D. Test-O.D. Control) / (O.D. Standard- O.D. Blank)] x 10 
Determination of bilirubin  
In toxic liver, bilirubin levels are elevated. Hyperbilirubinemia can result from 
impaired hepatic uptake of unconjugated bilirubin, such a situation can occur in 
generalized liver cell injury, certain drugs (e.g Rifampin and probenecid) interfere 
with the rat uptake of bilirubin by the liver cell and may produce a mild unconjugated 
hyperbilirubinemia. Bilirubin level rises in diseases of hepatocytes, obstruction to 
bilirubin excretion into duodenum, in haemolysis and defects of hepatic uptake and 
conjugation of Bilirubin pigment such as Gilbert’s disease.  
Elevation of total serum bilirubin may occur due to:  
1. Excessive haemolysis or destruction of the red blood cells.Eg:Haemolytic 
disease of the new born. 
2. Liver diseases.Eg.Hepatitis and cirrhosis. 
3. Obstruction of the biliary tract.Eg.Gall stones. 
The method is based on the reaction of Sulfonilic acid with sodium nitrite to form 
azobilirubin which has maximum absorbance at 546nm in the aqueous solution. The 
intensity of the color Produced is directly proportional to the amount of direct or total 
bilurubin concentration present in the sample. 
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Reagents 
1. Diazo A-(Reagent-R1) :Ready to use 
2.  Diazo B-(Reagent-R2):Ready to use 
3.  Bilirubin Activater :Ready to use 
Procedure 
Kind & King’s method was followed for the estimation of Bilirubin. Five 
hundred µl of working reagent was added to 50 µl of rat serum & incubated for 5 min 
at 37°C. Absorbance was measured AT 546 NM in semi auto analyzer against the 
standard. 
The Bilirubin content was calculated using the following equation: 
Total bilirubin (mg/dt) = Abs of the sample blank x 15. 
Direct Bilirubin(mg/dt) = Abs of sample blank x 10. 
 
6.2.5.DETERMINATION OF ANTIOXIDANT ENZYMES AND LIPID 
PEROXIDATION  
Preparation of tissue homogenate  
After treatment with ethanol extracts of both the plants, the rats were 
sacrificed, Kidney and liver of rats were isolated and washed with normal saline and 
stored for 12 h for in vivo antioxidant studies. The separated liver and kidneys were 
homogenized with motor driven Teflon coated homogenizer with 0.1 M Tris-HCl 
buffer (pH 7.4) to get 10% homogenate. The homogenate was centrifuged at 10000 
rpm for 10 min at 5˚C. The supernatant was collected and used for in vivo studies. 
Antioxidant enzymes viz. Superoxide dismutase (SOD)31,  Catalase (CAT)32, 
Glutathione peroxidise (GPX)33,  Reduced glutathione (GSH)34 and Lipid 
peroxidation (LPO)35  were determined in all the  liver tissues of all the tested rats  
 
Determination of proteins 
 
This method is a combination of both Folin-ciocalteau and Biuret reaction 
which involves two step reaction. In the first Step Protein binds with copper in 
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alkaline medium and reduces it to Cu++. In the second step Cu++ formed catalyses 
the oxidation reaction of aromatic amino acid by reducing Phosphomolybdotungstate 
to heteropolymolybdanum, which leads to the formation of blue colour which is 
measured at 640 nm.  
Reagents  
 Alkaline copper reagent  
 Solution A: 2 % w/v of sodium carbonate in 0.1 N NaOH.  
 Solution B: 0.5 % w/v copper sulphate in 1 % sodium potassium tartarate 50 
ml of  
 solution A was mixed with 1 ml of solution B just before use.  
 Folin's phenol reagent commercial reagent, 1:2 dilutions) bovine serum 
albumin (BSA) 
Procedure  
Lowry method was adopted for the estimation of total protein. (Lowry OH, 
Rosebrough NJ, Farr AL, Randall RJ, 1951. Protein measurement with the Folin 
phenol reagent. J Biol Chem 193: 265).To 0.1 ml of the liver homogenate, 0.9 ml of 
water, 4.5 ml of alkaline copper sulphate reagent were added and allowed to stand in 
the room temperature for 10 min. To this 0.5 ml of Folin’s reagent was added. After 
20 min, the blue colour developed was measured at 640 nm. The level of protein 
present was expressed as mg/g tissue or mg/dl.  
 Determination of superoxide dismutase  
 
Superoxide dismutase scavenges the superoxide radical (O●2) and thus 
provides a first line defence against free radical damage. Superoxide dismutase is an 
endogenous enzymatic antioxidant which catalyzes the dismutation of superoxide free 
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radical. This method is based on the inhibition of the spontaneous oxidation of the 
adrenaline to adrenochrome by the enzyme superoxide dismutase.  
2H2O + 2O2-                                                                         2H2O2 + O2 
Superoxide anion (O2-) interacts with peroxide to form hydroxyl radical (OH•) which 
causes damage in the absence of superoxide dismutase activity (R•) 
Reagents 
Carbonate buffer – 0.05M, pH 10.2: 1.14 g of sodium carbonate and 84 g of 
sodium bicarbonate were dissolved in 100 ml of distilled water. 
Ethylene diamine tetra acetate – 0.49M: 14.3 g of EDTA was dissolved in 100 
ml of distilled water. 
Epinephrine – 3M: 54 mg of epinephrine was dissolved in 100 ml of distilled 
water. 
Procedure 
SOD was estimated as per the procedure described by Kakkar et al. (Kakkar 
P. Das,. B. and Viswanathan .P.N. A modified spectrophotometic assay of SOD, Ind. 
J. Biochem. Biophy. 1984:21:130-132.). Liver homogenate (0.5 ml) was diluted with 
0.5 ml of distilled water. To this, 0.25 ml ethanol and 0.15 ml of chloroform, all 
reagents chilled, were added. The mixture was shaken for 1 minute and centrifuged at 
2000 rpm. The enzyme in the supernatant was determined. To 0.5 ml of the 
supernatant, 1.5 ml of buffer was added. The reaction was initiated by the addition of 
0.4 ml epinephrine and change in optical density per minute was measured at 480 nm 
in a double beam UV-VIS spectrophotometer (UV 1700,Szhimadzhu)  
SOD activity was expressed as U/mg. Change in optical density per minute at 
50% inhibition to adrenochrome transition by the enzyme is taken as one enzyme unit. 
 
Determination of catalase  
 
In animals, catalase is present in all major body organs, especially being 
concentrated in liver and erythrocyte. During β-oxidation of fatty acids by 
Superoxide dismutase  
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flavoprotien dehydrogenase, hydrogen peroxide is generated, which is accepted upon 
by Catalase present in peroxisomes. 
 Catalase catalyses the rapid decomposition of hydrogen peroxide to water.                           
          2H2O2                                                2H2O + O2 
Dichromate in acetic acid was converted to perchloric acid and then to chromic 
acetate when heated in presence of hydrogen peroxide. The chromic acetate thus 
produced is measured spectrophotometrically at 610 nm. The reaction is stopped at 
specific time interval by the addition of dichromate- acetic acid mixture and the 
remaining hydrogen peroxide is determined by measuring chromic acetate.  
Reagents 
Dichromate-acetic acid reagent: Five % potassium dichromate was prepared 
with acetic acid (1:3 v/v in distilled water). 
Phosphate buffer - 0.01M, pH 7.0: 173 mg of disodium hydrogen phosphate 
and 122 mg of sodium dihydrogen phosphate were dissolved in 200 ml of distilled 
water.  
Hydrogen peroxide – 0.2M: 2.27 ml of hydrogen peroxide was made upto 100 
ml with distilled water. 
Procedure 
The catalase activity was assayed by the method of Sinha (1972) (Sinha, A.K. 
Colorimetric assay off catalase Anal . Biochem. 1972: 47: 389-394 ). Liver 
homogenate (0.1 ml) was taken, to which 1.0 ml of phosphate buffer and hydrogen 
peroxide were added. The reaction was arrested by the addition of 0.2 ml dichromate 
acetic acid reagent. Standard hydrogen peroxide in the range of 4 to 20 µl were taken 
and treated similarly. The tubes were heated in a boiling water bath for 10 min. The 
green color developed was read at 570 nm in a Double beam UV-VIS 
spectrophotometer (UV 1700,Szhimadzhu).Catalase activity was expressed as U/mg. 
 
Catalase  
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 Determination of glutathione peroxidase 
Glutathione peroxidase catalyses the following reaction. 
                                           
R-COOH + 2GSH + O2                                       R-CH (OH)-COOH + GSSG + H2O 
Glutathione was measured by its reaction with DTNB to give a compound that 
absorbs at 412 nm.  
Reagents 
 Sodium phosphate buffer - 0.32M, pH 7.0: 6.96 g of disodium hydrogen 
phosphate and 3.89 g of sodium dihydrogen phosphate was dissolved in 200 
ml of distilled water. 
 Ethylene diamine tetra acetate (EDTA) - 0.8 mM: 233 mg of EDTA was 
dissolved in 100 ml of distilled water. 
 Sodium azide-10mM: 6.5 mg of sodium azide was dissolved in 100 ml of 
distilled water. 
 Reduced glutathione - 4 mM: 122 mg of glutathione was dissolved in 100 ml 
of distilled water. 
 Hydrogen peroxide - 2.5 mM: 0.03 ml of H2O2 was made up to 100 ml with 
distilled water. 
 Trichloro acetic acid - 10%: 10 g of TCA was dissolved in 100 ml of 
distilled water. 
 Disodium hydrogen phosphate - 0.3 M: 4.25 g of disodium hydrogen 
phosphate was dissolved in 100 ml of distilled water. 
 DTNB: 40 mg of 5,5’-dithio bis (2-nitrobenzoic acid) was dissolved in 100 
ml of 1% w/v sodium citrate. 
 Reduced glutathione standard: 20 mg of reduced glutathione was dissolved 
in 100 ml of distilled water. 
Procedure 
The glutathione peroxidase activity was measured according to the method of 
Rotruck et al., (1973) (Rotruck. J.T. pope , A.L. , Ganther , H.E. , Swanson , A.B., 
Glutathione peroxide   
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Hateman., D.G.., and Hoekstra ,  W.G., Selenium, biochemical roles as a component 
of glutathione peroxidase . J. Science, 1973: 179: 588-590.) 
EDTA (0.2 ml each), sodium azide, reduced glutathione, H2O2; 0.4 ml of 
buffer and 0.1 ml of enzyme (liver homogenate) were mixed and incubated at 37°C 
for 10 min. The reaction was arrested by the addition of 0.5 ml of TCA and the tubes 
were centrifuged. To 0.5 ml of supernatant, 3.ml of sodium hydrogen phosphate and 1 
ml of DTNB were added and the color developed was read at 412 nm immediately in 
a Double beam UV-VIS spectrophotometer (UV 1700,Szhimadzhu.Glutathione 
peroxidase activity, in serum is expressed as µg/mg. 
Determination of reduced glutathione  
 
           DTNB (5, 5’-dithiobis (2-nitrobenzoic acid)), known as Ellman’s 
Reagent, was used for the detection of thiol compounds. DTNB and glutathione 
(GSH) react to generate 2-nitro-5-thiobenzoic acid and glutathione disulfide 
(GSSG), where 2-nitro-5-thiobenzoic acid yield a stable yellow colored product, 
which is proportional to GSH concentration, measured at 412 nm. 
Reagents 
 10% TCA  
 0.6 mM 5,5’-dithiobis-2-nitrobenzoic acid (DTNB) in 0.2 M sodium 
phosphate  
 0.2 M Phosphate buffer, pH 8.0  
Procedure 
Reduced Glutathione was estimated by Ellman’s procedure.( Ellman G.L: 
Tissue sulphydryl groups: Archives in biochemistry and biophysics: 1959: vol 82 
(1):pp 70-77).To 250 L of tissue homogenate taken in 2 ml eppendroff tube, 1 mL of 
5% TCA was added and the above solution was centrifuged at 3000 g for 10 min at 
room temperature. To 250 L of the above supernatant, 1.5 ml of 0.2 M phosphate 
buffer was added and mixed well. 250 L of 0.6 mM of Ellman’s reagent (DTNB 
solution) was added to the above mixture and the absorbance was measured at 412 nm 
within 10 min. A standard graph was plotted using glutathione reduced solution (1 
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mg/ml) and GSH content present in the tissue homogenates was calculated by 
interpolation. Amount of glutathione expressed as g/mg protein. 
Determination of lipid peroxidation  
 
In this method malondialdehyde and other TBARS were estimated by their 
reactivity with thiobarbituric acid TBA) in acidic condition to generate a pink 
coloured chromophore which were read at 535 nm.  
Reagents:  
 TCA-TBA-HCl reagent: 15% w/v TCA, 0.375 w/v TBA and 0.25 N HCl. The 
solution was heated mildly to assist the dissolution of the TBA.  
 0.25 N HCl  
 15% TCA  
Procedure  
Lipid peroxidation was estimated by the method of Okhawa et al., (1979)( 
Okhawa, H, Ohishi, N and Yagi,  Assay for lipid peroxidase in animal tissue by 
thiobarbituric  acid reaction anal. Biochem, 1979:95; 351 – 8). one ml of liver 
homogenate was mixed with 0.2 ml 4 % (w/v) sodium dodecyl sulfate, 1.5 ml 20% 
acetic acid in 0.27 M hydrochloric acid (pH 3.5) and 15 ml of 0.8% thiobarbituric acid 
(TBA, pH 7.4). The mixture was heated in a hot water bath at 85˚C for 1 h. The 
intensity of the pink colour developed was read against a reagent blank at 532 nm 
following centrifugation at 1200 g for 10 min. The concentration was expressed as n 
moles of MDA per mg of protein using 1,1,3,3,-tetra-ethoxypropane as the standard. 
The results were tabulat 
Estimation of ascorbic acid   ( vitamin C) 
 The level of ascorbic acid was estimated by the method of Omaye et al.    1979). 
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Reagents 
 5% TCA 
 DTC reagent    3 g of 2,4-dinitrophenyl hydrazine, 0.4 g of thiourea and 0.05 g of 
copper sulphate were dissolved in 100 ml of 9 N sulphuric acid) 
 65% sulphuric acid 
 Ascorbic acid 
Procedure 
 To 0.5 ml of homogenate, 0.5 ml of water and 1 ml of TCA were added, mixed 
thoroughly and centrifuged. To 1 ml of the supernatant, 0.2 ml of DTC reagent was 
added and incubated at 37C for 3 hrs. Then 1.5 ml of sulphuric acid was added, mixed 
well and the solutions were allowed to stand at room temperature for another 30 min. 
The colour developed was read at 520 nm. 
 The level of ascorbic acid was expressed as g/mg protein. 
Estimation of vitamin E 
 The level of vitamin E was estimated by the method of Desai    1984). 
Reagents 
 1. Ethanol 
 2. Petroleum ether 
 3. 0.2% 4,6-diphenyl-1,10-phenanthroline in ethanol 
 4. 0.001 M Ferric chloride in ethanol 
 5. 0.001 M o-phosphoric acid in ethanol 
 6. -Tocopherol acetate 
Procedure 
 To 1 ml of homogenate, 1 ml of ethanol was added and thoroughly mixed. Then 
3 ml of petroleum ether was added, shaken rapidly and centrifuged. 2 ml of supernatant 
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was taken and evaporated to dryness. To this 0.2 ml of bathophenanthroline was added. 
The assay mixture was protected from light and 0.2 ml of ferric chloride was added 
followed by 0.2 ml of o-phosphoric acid. The total volume was made up to 3 ml with 
ethanol. The colour developed was read at 530 nm. 
 The level of vitamin E was expressed as g/mg protein. 
6.2.6 Statistical Analysis: 
 The data for various biochemical parameters were analyzed using analysis 
of variance    ANOVA) followed by Tukey multi comparison of all pairs of column. 
6.2.7 HISTOPHATOLOGICAL TECHINIQUES:  
 Histopathology is the microscopical study of tissues for pathological 
alterations. This involves collection of morbid tissues from biopsy or necropsy, 
fixation, preparation of sections, staining and microscopical examination. 
Collection of materials: 
         Thin pieces of 3 to 5 mm, thickness are collected from tissues showing gross 
morbid changes along with normal tissue. 
Fixation: 
 Keeping the tissue in fixative for 24-48 hours at room temperature 
a) Serves to harden the tissues by coagulating the cell protein, 
b) Prevents autolysis, 
c) Preserves the structure of the tissue, and  
d) Prevents shrinkage: The volume of the fixative added is 10times the volume of 
the tissues. 
Common Fixatives: 10% Formalin           
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Haematoxylin and eosin method of staining: 
 Deparaffinise the section by xylol 5 to 10 minutes and remove xylol by 
absolute alcohol, then wash in tap water. Stain with haematoxylin for 3-4 minutes and 
wash in tap water. Allow the sections in tap water 5-10 min and wash in tap water. 
Counter stain with 0.5% until section appears light pink (15 to 30seconds), and then 
wash in tap water. Blot and dehydrate in alcohol. Clear with xylol (15 to 30 seconds). 
Mount in Canada balsam or DPX Moutant. Keep slide dry and remove air bubbles. 
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7. RESULTS AND DISCUSSION 
7.1 RESULTS 
7.1.1  PRELIMINARY PHYTOCHEMICAL SCREENIG 
The results of the physiochemical, elemental analysis and quantitative 
estimation of phyto constituents followed by the pharmacological screening of various 
activities have been presented and discussed here below. In this study ethanolic 
extract of EPA (Extract of plumeria  acutifolia) showed positive to following 
phytochemical constituent’s alkaloids, carbohydrates, saponins, tannins, flavonoides, 
total phenolic substances, glycosides, carotenoids, fatty acids and  terpenoids. The 
results are tabulated in Table 1. 
Table. 8  Preliminary phytochemical screening of EPA (Extract of Plumeria 
Acutifolia) 
 
Name of the 
Phytoconstituents 
 
…….extract 
 
Carbohydrates 
 
Glycosides 
 
Alkaloids 
Phytosterol,steroids 
Proteins and Amino acids 
Flavanoids 
saponins 
 
Tri Terpenoids 
 
 
+ 
 
+ 
 
+ 
- 
+ 
+ 
+ 
 
+ 
(+) presence  , (-) absence 
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7.1.2 PHARMCOLOGICAL STUDIES 
 
Table.9  Body weight vs  Mean Servival Time 
 
 
 
 
 
 
 
 
 
 
 
 
Values arae expressed as mean ± SEM Statistical significance (p) calculated 
by one way ANOVA followed by dunnett’s(n=6); ns-non significant, p>0.05, 
**p<0.01, ***p<0.001, calculated by comparing treated groups with control group.  
 
 
 
 
 
Group CONTROL 
ONLY 
DAL DAL+5HT 
DAL+EXT 
100mg/kg 
DAL+EXT 
200mg/kg 
 
1ST 
WK 
 
21± 
1.34164 
 
54± 
33.6135 
 
17.8333± 
0.654047 
 
57.6667± 
32.8681 
 
23.3333± 
0.494413 
 
 
2ND 
WK 
 
24.3333± 
0.918937 
 
14.6667± 
6.56083 
 
24.6667± 
0.954521 
 
21.1667± 
6.804 
 
26.8333± 
5.46758 
 
 
3RD 
WK 
26.6667± 
0.666667 
 
21.1667± 
9.50935 
 
27.8333± 
1.6816 
 
24.5± 
7.86448 
 
24.5± 
7.77925 
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                                   Figure.7  Effect of  EPA on Body Weight  vs  MST 
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Table.10  Effect on MEAN SERVIVAL TIME 
Group CONTROL 
ONLY 
DAL DAL+5HT 
DAL+EXT 
100mg/kg 
DAL+EXT 
200mg/kg 
 
 
MES 
 
18.8333± 
2.16667 
 
12.8333± 
1.16667 
 
16.3333± 
1.8738 
 
15± 
1.98326 
 
18± 
1.54919 
 
 
 
Values arae expressed as mean ± SEM Statistical significance (p) calculated 
by one way ANOVA followed by dunnett’s(n=6); ns-non significant, p>0.05, 
**p<0.01, ***p<0.001, calculated by comparing treated groups with control group.  
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Figure.8  Mean Servival Time 
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                       Table.11 Effect on BODY WEIGHT  
 
Statistical comparison: Each group (n=6), each value represents Mean 
± SEM.One way ANOVA, followed by Dunnett comparison was performed. 
control group was compared with std group-II. (***P<0.001-**P<0.01, *P<0.05) 
treated groups III, IV,V was compared with group I. 
 
      
 
Figure.9 Body Weight 
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In body weight
Final body weight
Group CONTROL ONLY DAL 
DAL+5 FU 
20mg/kg 
DAL+Ext 
100mg/kg 
DAL+ Ext 
200mg/kg 
 
In body 
weight 
 
19.3333± 
1.11555 
 
15± 
0.447214*** 
 
16.3333± 
0.614636* 
 
22.3333± 
0.333333* 
 
21.6667± 
0.614636ns 
 
 
Final 
body 
weight 
 
 
24± 
1.12546 
 
 
25± 
8.07878 
 
 
16.6667± 
5.33333 
 
 
26.1667± 
8.37622 
 
 
19.1667± 
6.14501 
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                             Table.12 Effect on TUMOR VOLUME 
 
Statistical comparison: Each group (n=6), each value represents Mean 
± SEM.One way ANOVA, followed by Dunnett comparison was performed. 
control group was compared with std group-II. (***P<0.001-**P<0.01, *P<0.05) 
treated groups III, IV,V was compared with group I. 
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                                    Figure.10  Tumor Volume 
 
Group CONTROL 
ONLY 
DAL 
DAL+5 FU 
20mg/kg 
DAL+Ext 
100mg/kg 
DAL+ Ext 
200mg/kg 
 
Tumor 
volume 
 
0±0 
 
7.86667± 
2.8378 
 
3.4± 
2.05913 
 
7.16667± 
3.24722 
 
4.08333± 
1.96815 
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HEMATOLOGICAL  PARAMETERS 
                         Table.13 Effects on  Hematological  Parameter 
 
 
Statistical comparison: Each group (n=6), each value represents Mean 
± SEM.One way ANOVA, followed by Dunnett comparison was performed. 
control group was compared with std group-II. (***P<0.001-**P<0.01, *P<0.05) 
treated groups III, IV,V was compared with group I. 
 
 
 
 
 
Group CONTROL 
ONLY 
DAL 
DAL+5 FU 
20mg/kg 
DAL+Ext 
100mg/kg 
DAL+ Ext 
200mg/kg 
Rbc 
5.31±0.1579
87 
4.93333±0.2
14051 
4.45667±0.2
11702 
4.95±0.291
136 
4.54±0.152
883 
Wbc 
12.6±0.7293
83 
35.5667±3.5
9153*** 
22.5±1.5288
3** 
21.8667±1.
53594** 
31.6667±0.
9895*** 
Total 
Haemoglobin 12.9333±0.4
70933 
11.8±0.6366
58 
10.3667±0.6
43256 
11.8333±0.
875087 
10.5333±0.
421637 
Packed Cell 
Volume 39.8333±1.4
2797 
36.5333±1.9
6141 
32.2667±1.8
2805 
36.1667±2.
41449 
32.5667±1.
57917 
Polymorphs 
4.33333±0.7
60117 
13±1.09545
*** 9±0.966092 
7.66667±1.
47573 
13±1.9321
8*** 
Lymphocytes 
89.3333±1.5
2023 
81±1.31656
*** 
83.6667±1.1
7379* 
86.6667±1.
83787 
80.6667±1.
83787*** 
Monocytes 2.66667±0.2
10819 
4.33333±0.2
10819** 4±0.365148* 
2.66667±0.
421637 
2.66667±0.
210819 
Eosinophils 3.66667±0.5
57773 5±0.365148 
3.33333±0.5
57773 
3±0.36514
8 
3.66667±0.
557773 
Mch 26.1333±0.1
28236 
25.3333±1.3
9778 
21.8667±0.7
49518*** 
25.1667±0.
310555 
24.3667±0.
243128 
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Figure.11 Effect on  RBC 
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Figure.12 Effect on WBC 
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Figure.13  Effect on Total Hemoglobin 
Packed Cell Volume
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Figure.14 Effect on Packed Cell Volume 
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POLYMORPHS
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Figure.15. Effect on Polymers 
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Figure.16  Effect on Lymphocytes 
 
 
Department of Pharmacology                     70                    J.K.K.Nataraja College of Pharmacy 
 
 
MONOCYTES
CO
NT
RO
L
ON
LY
 D
AL
DA
L+
5 F
U 
20
mg
/kg
 
DA
L+
EX
T 1
00
mg
/kg
DA
L+
EX
T 2
00
mg
/kg
0
1
2
3
4
5
%
 
Figure.17 Effect on Monocytes 
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Figure.18 Effect on Eosinophils 
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Figure.19 Effect on MCH 
 
 
PACKED CELL VOLUME 
                             Table.14  Effect On Packed Cell Volume 
CONTROL CONTROL 
ONLY 
DAL 
DAL+5HT 
20mg/kg 
DAL+EXT
100 mg/kg 
DAL+EXT
200mg/kg 
 
Packed Cell 
Volume 0±0 
3.03333±0.6
41179*** 
0.923333±0
.023758 
3.1±0.3346
64*** 
2.7±0.1095
45*** 
 
Statistical comparison: Each group (n=6), each value represents Mean 
± SEM.One way ANOVA, followed by Dunnett comparison was performed. 
control group was compared with std group-II. (***P<0.001-**P<0.01, *P<0.05) 
treated groups III, IV,V was compared with group I. 
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Figure.20  Effect on Packed Cell Volume 
 
TOTAL PROTEIN CONTENT 
Table.15 Effect on Total Protein Content 
Group CONTROL ONLY DAL 
DAL+5HT 
20mg/kg 
DAL+EXT
100 mg/kg 
DAL+EXT
200mg/kg 
 
Total protein 
(mg/dl) 
6.73333±0.
0760117 
5.86667±0.0
760117*** 
5.03333±0.
0557773**
* 
6.13333±0.
18738** 
6.2±0.0966
092** 
 
Statistical comparison: Each group (n=6), each value represents Mean 
± SEM.One way ANOVA, followed by Dunnett comparison was performed. 
control group was compared with std group-II. (***P<0.001-**P<0.01, *P<0.05) 
treated groups III, IV,V was compared with group I. 
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Figure.21 Effect on Total Protein 
  
TOTAL BILRUBIN 
Table.16 Effect on Total Bilrubin 
Group CONTROL ONLY DAL 
DAL+5HT 
20mg/kg 
DAL+EXT
100 mg/kg 
DAL+EXT
200mg/kg 
 
Total bilirubin 
(mg/dl) 
0.616667±0
.0462361 
0.953333±0.
0374759*** 
0.666667±0
.0402216 
0.826667±0
.040387** 
0.656667±
0.0314819 
 
Statistical comparison: Each group (n=6), each value represents Mean 
± SEM.One way ANOVA, followed by Dunnett comparison was performed. 
control group was compared with std group-II. (***P<0.001-**P<0.01, *P<0.05) 
treated groups III, IV,V was compared with group I. 
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Figure.22 Effect on Total Bilrubin 
LIVER ENZYMES 
Table.17  Effect on Liver Enzymes 
Group 
CONTRO
L 
ONLY 
DAL 
DAL+5HT 
20mg/kg 
DAL+EXT10
0 mg/kg 
DAL+EXT200mg/k
g 
 
SGOT(U/L
) 
87.7± 
2.35542 
205.367± 
23.0248**
* 
173.4± 
10.8622**
* 
199.4± 
8.96423*** 
170.467± 
5.72088*** 
 
SGPT(U/L
) 
61.1± 
2.41744 
59.8333± 
3.36736 
77.8± 
9.12403 
71.1333± 
8.55619 
55.6± 
7.7439 
 
ALP (U/L) 
146.233± 
8.01352 
19.3333± 
2.29211 
27.8± 
2.94211 
58.9367± 
16.1998 
38.4± 
6.27981 
 
Statistical comparison: Each group (n=6), each value represents Mean 
± SEM.One way ANOVA, followed by Dunnett comparison was performed. 
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control group was compared with std group-II. (***P<0.001-**P<0.01, *P<0.05) 
treated groups III, IV,V was compared with group I. 
 
SGOT
CO
NT
RO
L
ON
LY
 D
AL
DA
L+
5H
T 2
0m
g/k
g
DA
L+
EX
T1
00
 m
g/k
g
DA
L+
EX
T2
00
mg
/kg
0
50
100
150
200
250
U
/L
 
 Figure.23 Effect on Serum Glutamate Oxalo Acetate Transaminase 
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Figure.24 Effect on Serum Glutamate Pyruvate Transaminase 
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Figure.25  Effect on Alkaline Phosphatase 
URINARY CONTENTS 
Table.18 Effect on Urinary Content 
Group 
CONTRO
L ONLY DAL 
DAL+5H
T 
20mg/kg 
DAL+EXT1
00 mg/kg 
DAL+EXT200
mg/kg 
UREA 
(mg/dl) 
37.6667± 
2.85315 
55.4667± 
3.00762 
57.4333± 
3.80006 
81.1± 
5.52606*** 
40.1± 
0.438 
CREATI
NINE 
(mg/dl) 
0.9033± 
0.08826 
 
0.3033± 
0.0117*** 
 
0.5033± 
0.038 
 
1.136± 
0.0947*** 
 
0.37± 
0.02*** 
 
Uric acid 
(mg/dl) 
2.203±0.13
7421 
1.157±0.1186
78*** 
2.233±0.0
8558 
1.183±0.080
52*** 2.383±0.171 
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Statistical comparison: Each group (n=6), each value represents Mean 
± SEM.One way ANOVA, followed by Dunnett comparison was performed. 
control group was compared with std group-II. (***P<0.001-**P<0.01, *P<0.05) 
treated groups III, IV,V was compared with group I. 
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Figure.26 Effect on Urea 
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Figure.27 Effect on Creatinine 
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Figure.28 Effect on Uric Acid 
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LIPID PROFILE 
                                   Table.19 Effect on Lipid Profile 
 
 
 
Statistical comparison: Each group (n=6), each value represents Mean 
± SEM.One way ANOVA, followed by Dunnett comparison was performed. 
control group was compared with std group-II. (***P<0.001-**P<0.01, *P<0.05) 
treated groups III, IV,V was compared with group I. 
 
 
 
 
Group 
CONTRO
L 
ONLY 
DAL 
DAL+5H
T 
20mg/kg 
DAL+EXT10
0 mg/kg 
DAL+EXT200mg/
kg 
Total 
cholesterol 
(mg/dl) 
76.3±2. 
80785 
92.5333
± 
6.98669 
98.6± 
12.1218 
63.1± 
7.18563 
90.1333± 
9.12757 
triglyceride
s (mg/dl) 60.9±5. 
27295 
90.5333
± 
12.9007 
175.2± 
32.6986*
* 
25.8± 
6.45972 
142.133± 
38.7123* 
HDL-
Cholesterol 
(mg/dl) 
46.6667± 
1.73449 
43.7667
± 
1.46075 
34.6333± 
4.3418** 
 
35.8333± 
1.92435* 
39.6667± 
0.713987 
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Figure.29 Effect on Total Cholesterol 
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Figure.30  Effect on Triglycerides 
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                                Figure.31 Effect on High Density Lipoprotein 
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  EFFECT OF EXTRACT ON ANTIOXIDANT LEVELS 
                                  Table.20 Effect on anti Oxidant Level 
Group CONTROL 
ONLY 
DAL 
DAL+5HT 
20mg/kg 
DAL+EXT
100 mg/kg 
DAL+EXT200m
g/kg 
 
SOD 
 
5.71±0.50 
 
2.70±0.30 
 
6.23±0.25 
 
4.73±0.17 
 
3.96±0.18 
 
Catala
se 
 
86.17±3.92
*** 
 
50.17±2.31
*** 
 
87.17±2.85
*** 
 
74.50±1.87
*** 
 
 
65.00±2.36*** 
 
LPO 
 
8.85±0.81*
** 
 
36.50±1.51
*** 
 
13.50±1.87
*** 
 
24.67±2.50
*** 
 
20.17±0.98*** 
 
GPx 
 
45.50±2.42
*** 
 
20.67±1.21
*** 
 
50.17±2.13
*** 
 
35.00±2.00
*** 
 
41.67±1.96*** 
 
GSH 
 
32.67±1.63
*** 
 
14.67±1.03
*** 
 
36.33±1.63
*** 
 
19.67±1.03
*** 
 
30.17±0.98*** 
 
Vitami
n C 
 
1.30±0.10*
** 
 
0.27±0.04*
** 
 
1.21±0.10*
** 
 
0.75±0.05*
** 
 
0.96±0.16*** 
 
Values are expressed as mean ± S.D. Statistical significance (p) was calculated 
by one way ANOVA followed by Tukey multiple comparisontest. Control group was 
compared with normal. Standard and test groups were compared with control. ***P< 
0.05wasconsideredsignificant. 
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Figure.32 Effect on Superoxide Dimutase 
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Figure.33 Effect on Catalase 
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Figure.34 Effect on Lipid Peroxidation 
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Figure.35 Effect on Glutathione 
 
 
 
Department of Pharmacology                     85                    J.K.K.Nataraja College of Pharmacy 
 
 
GPx
CO
NT
RO
L
ON
LY
 D
AL
DA
L+
5H
T 2
0m
g/k
g
DA
L+
EX
T1
00
 m
g/k
g
DA
L+
EX
T2
00
mg
/kg
0
20
40
60
ug
 o
f G
SH
/m
g 
of
 p
ro
te
in
 
Figure.36 Effect on Glutathione Peroxidase  
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Figure.37 Effect on Vitamin C 
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7.1.3 HISTOPATHOLOGY 
GROUP   -   I CONTROL  
Section studied from the liver shows normal lobular architecture. Hepatocyte 
shows normal morphology with foci of lobularinflammation.Contral vein shows 
normal. 
GROUP   –   II   ONLY DAL 
Section studied from the liver shows preserved lobular architecture.Few foci 
shows lympoplasmacytic infiltration with proliferation of thin walled 
vessels.Hepatocyte shows normal morphology. Portal tract shows normal.Contral vein 
shows mild dilatation.Sinusoids show dilatation. 
GROUP   –   III DAL+ 5FU 20mg/kg 
Section studied from the liver shows maintained lobular architecture. 
Hepatocyte shows normal morphology. Portal tract shows normal.Contral vein and 
Sinusoids shows mild dilatation.There is no evidence of inflammation/necrosis. 
GROUP   -   IV DAL+ EXT 100mg/kg 
Section studied from the liver shows maintained lobular architecture. 
Hepatocyte shows normal morphology with foci of lobularinflammation.Portal tract 
shows mild lymphocytic infiltration. Contral vein shows normal.Sinusoids show mild 
dilatation. 
GROUP   –   V DAL + EXT 200mg/kg 
Section studied from the liver shows maintained lobular architecture. 
Hepatocyte shows normal morphology. Portal tract shows normal. Contral vein shows 
normal. Sinusoids show mild dilatation.Peripheri shows dense lymphoplasmacytice 
infiltration is seen. 
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CONTROL 
        
                  ONLY DAL                                   DAL+ 5FU20mg/kg 
           
             DAL+ EXT100mg/kg                              DAL + EXT200mg/kg   
             Figure.38 Histopathology of DAL induced and EPA treated cells 
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 b  
Figure.39 Shows Effect Of Map On Viable And Non-Viable Cell Count after 13 days 
treatment    A: DAL control; B: DAL + 5-FU, 20 mg/kg body weight; C: DAL +EPA, 
100 mg/kg body weight;         D: DAL + MAP,200 mg/kg body weight 
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                    ONLY DAL                                       DAL+ 5FU 20mg/kg ip 
  
      DAL + EPA 250mg/kg (p.o)                              DAL + EPA 500mg/kg( p.o)     
Figure.40 EFFECT OFETHANOLIC EXTRACT OF  Plumeria acutifolia Poir 
ON DAL INDUCED CANCER IN MICE 
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7.2 DISCUSSION 
 
The preliminary phytochemical studies of EPA indicated the presence of 
several triterpenoids, phenols, Flavonoids, tannins, glycosides, and so on. The 
observed antitumor, hepatoprotective, and antioxidant activities may be due to the 
presence of any of these compounds in EPA. 
Bioactive antioxidant levels:   
  Flavonoids are a group of effective antioxidants which are present 
abundantly throughout the plant kingdom. Flavonoid and related compound are 
effective in scavenging DPPH radical, hydroxyl radical and in metal-chelating 
capacity Flavonoids are found to exhibit numerous biological activities like 
vasodilator, anticarcinogenic, anti-inflammatory, antibacterial, immune-stimulating, 
antiallergic, and antiviral effects 14, 15. 
  Tannins, the high molecular weight phenols, act as a good scavenger of free 
radical either by donating hydrogen atom or by reducing them. This property is 
attributed by the molecular weight, the number of aromatic rings and nature of 
hydroxyl group’s substitution and specific functional groups present in the tannins. 
The results show that the methanol extract contains more tannin.55 
 Phenols are very important plant constituents because of their radical 
scavenging ability due to the hydroxyl groups. Polyphenols are known to exhibit a 
variety of biological actions such as free radicals scavenging, metal chelation, 
modulation of enzyme activity and more recently to effect signal transduction, 
activation of transcription factors and gene expression.56 
DAL-induced ascitic antitumor studies 
               The reliable criteria for judging the value of an anticancer drug is the 
prolongation of the life span of animals. In DAL-tumor-bearing mice, a regular rapid 
increase in ascitic tumor volume was observed62. The DAL-bearing mice orally 
administered EPA at 100 and 200 mg/kg body weight showed significant change in 
the average life span compared to animals of the tumor control group. However, the 
percent increase in body weight, tumor cell volume, and number of viable tumor cells 
were found to be significantly less than the tumor control animals, indicating the 
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anticancer nature of the extract enumerated in the table no.12. These results could 
indicate either a direct cytotoxic effect of EPA on tumor cells as evidenced by the in 
vitro studies or an indirect local effect, which may involve macrophage activation and 
vascular permeability inhibition. Hence, the observed antitumor nature of EPA may 
be due to the cytotoxic properties.  
   In cancer chemotherapy the major problems are of myelosuppression and 
anaemia70,71   
Anaemia  encountered  in  tumour  bearing mice  is mainly  due  to  reduction  
in RBC and HB% and  this may occur either due to  iron deficiency or due  to 
hemolytic or myelopathic conditions.72 However, the elevation of WBC levels may be 
due to its adverse effect on the haemopoietic system58 
   
The reversal of Hgb content, RBC, Total WBC, and differential count of WBC 
by the EPA treatment towards the values of the normal group clearly indicates that 
EPA possessed protective action on the haemopoietic system ( Table.13). 
 
Biochemical parameters: The inoculation of DAL cells caused significant 
increases in the levels of TGL, TP, TC, ALP61 and ALBUMIN and there is no 
significant change in the levels of ASAT and ALAT in the serum of tumor control 
animals, when compared to the normal group.The treatment with EPA at 100 and 200 
mg/kg body weight reversed these changes towards the normal levels (Table.14 to 
17). Most of the values were found to be significant. The treatment with standard 5-
FU also gave similar results. 
            The antioxidant nature of EPA was also evident by the in vitro studies. Plants 
with high total phenol content are known to possess strong antioxidant properties60. 
The observed antioxidant activity may be due to the high phenolic content of the 
extract.  
It was observed that tumor cells produced more peroxides when they 
proliferate actively after inoculation of tumor. This rise in peroxides indicated the 
occurrence of intensification of oxygen free radical production62. Cells which are 
equipped with enzymatic antioxidant mechanisms play an important role in the 
elimination of free radicals. High levels (up to 0.05 µmol/h per 104 cells) of H2O2 are 
constitutively released from a wide variety of human tumors 64.  
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Lipid peroxidation mediated by free radicals considered being a primary 
mechanism of cell membrane destruction and cell damage. The oxidation of 
unsaturated fatty acids in biological membrane leads in reduction membrane fluidity 
and disruption of membrane structure and function. MDA, the end product of lipid 
peroxidation was also reported to be higher in carcinomatous tissue than in non-
diseased organs. Increase in levels of TBARS indicate enhanced lipid peroxidation 
leading to tissue injury and failure of antioxidant defense mechanism to prevent the 
formation of excess free radicals.  
Administration of EPA significantly decreases the liver TBARS.  Table.20 
represents LPX levels. 
             The active role of GSH against cellular lipid peroxidation has been well 
recognized and there by reduces the glutathione (GSH) activity.GSH can act either to 
detoxify activate oxygen species such as H2O2 or reduce lipid peroxidation and 
increased the levels of glutathione content and there by it may act as an anti tumor 
agent.63  
Administration of EPA significantly decreases the liver glutathione. Table.20 
represents GSH levels. 
            On the other hand, SOD is aubiquitous chain breaking anti oxidant and is 
found in all aerobic organisms. It is mettalo protein widely distributed in all cells and 
plays an important protective role against ROS-induced Oxidative damage. The 
radical scavenging system catalase, which are present in all major organsims in body 
of animals and human beings and is especially concentrated in liver and erythrocytes . 
Both enzymes play an imp role in the elimination of ROS derived from the redox 
process of xenobiotic in liver tissues. It was suggested that catalase and SOD are 
easily inactivated by lipid peroxidase or ROS in correlation it has been reported that 
DAL bearing mice shows decreased levels of SOD activity and this may be due to 
loss of MN++ SOD activity in, liver inhibition of  catalase activity  in tumor cell lines 
also reported65,66. In this study, catalase and SOD were appreciable elevated by 
administration of EPA (Table.20 represents SOD and Catalase levels). 
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Histopathological analysis 
Histological observation of liver under a light microscope was done to observe 
the effect of MAP on the structural integrity of the cells. 
The liver of normal animal showed normal histological appearance 
(Figure.38). 
The tumor control animal liver showed slight enlargement of hepatocytes, 
dilated sinusoidal spaces containing and portal triads showing collections of 
lymphocytes  
The animals treated with standard 5-Fu at 20 mg/kg i.p shows normal 
histological appearance of liver cells with no lymphocytes in the portal area  
The animals treated with EPA  at 100mg/kg and 200mg/kg body weight 
showed almost normal histological appearance of liver cells, except for a few 
lymphocytic collections in the portal area  
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8.SUMMARY AND CONCLUSION 
 
The present dissertation work was carried out to evaluation of anticancer 
activity of ethanol extract of plumeria acutifolia leaf against Dalton's ascites 
lymphoma (DAL) induced cancer in mice. plumeria acutifolia were extracted with 
ethanol and the chemical constituents of the extract were identified by qualitative 
analysis.Preliminary phytochemical analysis of plumeria acutifolia showed the 
positive test of as carbohydrate, alkaloid, glycosides, saponins, flavanoids, 
triterpenoids, proteins.  
Further anticancer and antioxidant studies of EPA against dalton's ascites 
lymphoma (DAL) in cancer mice increased the life span by arresting the tumor 
growth. Administration of EPA of the dose of 100 and 200 mg / kg in DAL bearing 
mice significantly increased the haemoglobin level,RBC count as well as reduce in 
WBC count. when comparision with DAL induced  and after administration of the 
100 and 200 mg of EPA extract shows decrease in LPX, decreases the GSH level and 
elevated SOD level.  
These all results shows that the drug plumeria acutifolia confirmed to have 
anticancer activity and antioxidant activity may due to the presence of saponins, 
flavanoids, triterpenoids, etc.  
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